# Analog Devices timeline

entity: /record/analog-devices.md  
id: ent_analog-devices  

Analog Devices' timeline holds 574 money & deals claims from 2006 to 2026. The latest took effect on August 1, 2026.

Kinds: People 3 (/timelines/analog-devices.md?kind=people) · Money & deals 574 (/timelines/analog-devices.md?kind=money) · Products 0 (/timelines/analog-devices.md?kind=products) · Models 0 (/timelines/analog-devices.md?kind=models) · Other 8 (/timelines/analog-devices.md?kind=other) · every kind: /timelines/analog-devices.md  
Format: date | kind | predicate | value | status | claim.

## 2006

- 2006-10-28 to 2007-11-03 | money | cash_and_equivalents | 343,947,000 United States dollar | superseded | [clm_0304D6EC50A5](/claim/clm_0304D6EC50A5.md)

## 2007

- 2007-11-03 to 2008-08-02 | money | cash_and_equivalents | 424,972,000 United States dollar | superseded | [clm_E91498E23156](/claim/clm_E91498E23156.md)
- 2007-11-03 to 2008-11-01 | money | operating_income | 568,723,000 United States dollar | superseded | [clm_76777633CFC3](/claim/clm_76777633CFC3.md)
- 2007-11-03 to 2008-11-01 | money | research_and_development | 509,553,000 United States dollar | superseded | [clm_E5D91DD1F4AB](/claim/clm_E5D91DD1F4AB.md)
- 2007-11-03 to 2008-11-01 | money | revenue | 2,464,721,000 United States dollar | superseded | [clm_1C09F98C7435](/claim/clm_1C09F98C7435.md)

## 2008

- 2008-08-02 to 2008-11-01 | money | cash_and_equivalents | 418,456,000 United States dollar | superseded | [clm_905ED84CAF38](/claim/clm_905ED84CAF38.md)
- 2008-08-02 to 2009-01-31 | money | quarterly_operating_income | 161,190,000 United States dollar | superseded | [clm_C7EA42532AE0](/claim/clm_C7EA42532AE0.md)
- 2008-08-02 to 2009-01-31 | money | quarterly_research_and_development | 135,837,000 United States dollar | superseded | [clm_15E2FDDCA3D2](/claim/clm_15E2FDDCA3D2.md)
- 2008-08-02 to 2009-01-31 | money | quarterly_revenue | 658,986,000 United States dollar | superseded | [clm_DE806AA67132](/claim/clm_DE806AA67132.md)
- 2008-11-01 to 2009-01-31 | money | cash_and_equivalents | 593,599,000 United States dollar | superseded | [clm_AF75AEE350F4](/claim/clm_AF75AEE350F4.md)
- 2008-11-01 to 2009-10-31 | money | operating_income | 625,025,000 United States dollar | superseded | [clm_174DA55F1895](/claim/clm_174DA55F1895.md)
- 2008-11-01 to 2009-10-31 | money | research_and_development | 533,480,000 United States dollar | superseded | [clm_53D441FDE0F8](/claim/clm_53D441FDE0F8.md)
- 2008-11-01 to 2009-10-31 | money | revenue | 2,582,931,000 United States dollar | superseded | [clm_6EAAD88535F4](/claim/clm_6EAAD88535F4.md)
- 2008-11-01 to 2009-08-01 | money | total_assets | 3,090,992,000 United States dollar | superseded | [clm_81893656F11A](/claim/clm_81893656F11A.md)
- 2008-11-01 to 2009-08-01 | money | total_equity | 2,420,263,000 United States dollar | superseded | [clm_895CCCDB5843](/claim/clm_895CCCDB5843.md)

## 2009

- 2009-01-31 to 2009-05-02 | money | cash_and_equivalents | 769,713,000 United States dollar | superseded | [clm_C749C94D7C2F](/claim/clm_C749C94D7C2F.md)
- 2009-01-31 to 2009-05-02 | money | quarterly_operating_income | 19,591,000 United States dollar | superseded | [clm_364503277B23](/claim/clm_364503277B23.md)
- 2009-01-31 to 2009-05-02 | money | quarterly_research_and_development | 119,828,000 United States dollar | superseded | [clm_93851FDD776A](/claim/clm_93851FDD776A.md)
- 2009-01-31 to 2009-05-02 | money | quarterly_revenue | 476,569,000 United States dollar | superseded | [clm_756826AB6486](/claim/clm_756826AB6486.md)
- 2009-05-02 to 2009-08-01 | money | cash_and_equivalents | 676,879,000 United States dollar | superseded | [clm_E5054752AE37](/claim/clm_E5054752AE37.md)
- 2009-05-02 to 2009-08-01 | money | quarterly_operating_income | 57,909,000 United States dollar | superseded | [clm_5B8E9AE9ED4C](/claim/clm_5B8E9AE9ED4C.md)
- 2009-05-02 to 2009-08-01 | money | quarterly_research_and_development | 109,448,000 United States dollar | superseded | [clm_32C11C2635D3](/claim/clm_32C11C2635D3.md)
- 2009-05-02 to 2009-08-01 | money | quarterly_revenue | 474,748,000 United States dollar | superseded | [clm_CB22D6C55B60](/claim/clm_CB22D6C55B60.md)
- 2009-08-01 to 2009-10-31 | money | cash_and_equivalents | 632,715,000 United States dollar | superseded | [clm_80A62541466B](/claim/clm_80A62541466B.md)
- 2009-08-01 to 2010-01-30 | money | quarterly_operating_income | 78,945,000 United States dollar | superseded | [clm_747B19F77865](/claim/clm_747B19F77865.md)
- 2009-08-01 to 2010-01-30 | money | quarterly_research_and_development | 107,578,000 United States dollar | superseded | [clm_6F49739E25B7](/claim/clm_6F49739E25B7.md)
- 2009-08-01 to 2010-01-30 | money | quarterly_revenue | 491,991,000 United States dollar | superseded | [clm_BB2D8E82DCB9](/claim/clm_BB2D8E82DCB9.md)
- 2009-08-01 to 2009-10-31 | money | shares_outstanding | 291,549,108 shares | superseded | [clm_23646884B82C](/claim/clm_23646884B82C.md)
- 2009-08-01 to 2009-10-31 | money | total_assets | 3,280,151,000 United States dollar | superseded | [clm_00D9CB0AC1E7](/claim/clm_00D9CB0AC1E7.md)
- 2009-08-01 to 2009-10-31 | money | total_equity | 2,458,365,000 United States dollar | superseded | [clm_D0BB17548000](/claim/clm_D0BB17548000.md)
- 2009-10-31 to 2010-01-30 | money | cash_and_equivalents | 639,729,000 United States dollar | superseded | [clm_607329259019](/claim/clm_607329259019.md)
- 2009-10-31 to 2010-10-30 | money | net_income | 247,772,000 United States dollar | superseded | [clm_0069F44F5B4E](/claim/clm_0069F44F5B4E.md)
- 2009-10-31 to 2010-10-30 | money | operating_income | 284,817,000 United States dollar | superseded | [clm_FC2A97CB9FB1](/claim/clm_FC2A97CB9FB1.md)
- 2009-10-31 to 2010-10-30 | money | research_and_development | 446,980,000 United States dollar | superseded | [clm_8EF456B6329F](/claim/clm_8EF456B6329F.md)
- 2009-10-31 to 2010-10-30 | money | revenue | 2,014,908,000 United States dollar | superseded | [clm_A3855B85270F](/claim/clm_A3855B85270F.md)
- 2009-10-31 to 2010-01-30 | money | shares_outstanding | 291,861,767 shares | superseded | [clm_9F2F82151F63](/claim/clm_9F2F82151F63.md)
- 2009-10-31 to 2010-01-30 | money | total_assets | 3,404,294,000 United States dollar | superseded | [clm_F039ADF0AEF0](/claim/clm_F039ADF0AEF0.md)
- 2009-10-31 to 2010-01-30 | money | total_equity | 2,529,149,000 United States dollar | superseded | [clm_C138840F449A](/claim/clm_C138840F449A.md)

## 2010

- 2010-01-30 to 2010-05-01 | money | cash_and_equivalents | 914,268,000 United States dollar | superseded | [clm_F4FC5F3C8B74](/claim/clm_F4FC5F3C8B74.md)
- 2010-01-30 to 2010-05-01 | money | quarterly_net_income | 120,459,000 United States dollar | superseded | [clm_D9488506F134](/claim/clm_D9488506F134.md)
- 2010-01-30 to 2010-05-01 | money | quarterly_operating_income | 149,114,000 United States dollar | superseded | [clm_A86C4F73FF93](/claim/clm_A86C4F73FF93.md)
- 2010-01-30 to 2010-05-01 | money | quarterly_research_and_development | 114,398,000 United States dollar | superseded | [clm_3161CFF25392](/claim/clm_3161CFF25392.md)
- 2010-01-30 to 2010-05-01 | money | quarterly_revenue | 602,983,000 United States dollar | superseded | [clm_1700257DD146](/claim/clm_1700257DD146.md)
- 2010-01-30 to 2010-05-01 | money | shares_outstanding | 297,690,739 shares | superseded | [clm_5AD3871276FF](/claim/clm_5AD3871276FF.md)
- 2010-01-30 to 2010-05-01 | money | total_assets | 3,698,170,000 United States dollar | superseded | [clm_5C7765E622F8](/claim/clm_5C7765E622F8.md)
- 2010-01-30 to 2010-05-01 | money | total_equity | 2,764,153,000 United States dollar | superseded | [clm_8D110056932B](/claim/clm_8D110056932B.md)
- 2010-05-01 to 2010-07-31 | money | cash_and_equivalents | 1,008,372,000 United States dollar | superseded | [clm_DFB8B52E9D40](/claim/clm_DFB8B52E9D40.md)
- 2010-05-01 to 2010-07-31 | money | quarterly_net_income | 167,140,000 United States dollar | superseded | [clm_8F2BA3836649](/claim/clm_8F2BA3836649.md)
- 2010-05-01 to 2010-07-31 | money | quarterly_operating_income | 214,075,000 United States dollar | superseded | [clm_19867E9EFF5A](/claim/clm_19867E9EFF5A.md)
- 2010-05-01 to 2010-07-31 | money | quarterly_research_and_development | 122,780,000 United States dollar | superseded | [clm_B1C98ECB2BF1](/claim/clm_B1C98ECB2BF1.md)
- 2010-05-01 to 2010-07-31 | money | quarterly_revenue | 668,240,000 United States dollar | superseded | [clm_8D7C4EAA4D7D](/claim/clm_8D7C4EAA4D7D.md)
- 2010-05-01 to 2010-07-31 | money | shares_outstanding | 297,981,270 shares | superseded | [clm_77267AB45461](/claim/clm_77267AB45461.md)
- 2010-05-01 to 2010-07-31 | money | total_assets | 3,928,097,000 United States dollar | superseded | [clm_CA5609B1DEC0](/claim/clm_CA5609B1DEC0.md)
- 2010-05-01 to 2010-07-31 | money | total_equity | 2,890,250,000 United States dollar | superseded | [clm_E97056D2FFE5](/claim/clm_E97056D2FFE5.md)
- 2010-07-31 to 2010-10-30 | money | cash_and_equivalents | 993,429,000 United States dollar | superseded | [clm_88530764C5AB](/claim/clm_88530764C5AB.md)
- 2010-07-31 to 2011-01-29 | money | quarterly_net_income | 199,491,000 United States dollar | superseded | [clm_2B010B91382B](/claim/clm_2B010B91382B.md)
- 2010-07-31 to 2011-01-29 | money | quarterly_operating_income | 251,145,000 United States dollar | superseded | [clm_1CA606608326](/claim/clm_1CA606608326.md)
- 2010-07-31 to 2011-01-29 | money | quarterly_research_and_development | 126,987,000 United States dollar | superseded | [clm_A4E3DDA159DA](/claim/clm_A4E3DDA159DA.md)
- 2010-07-31 to 2011-01-29 | money | quarterly_revenue | 720,290,000 United States dollar | superseded | [clm_828C28EA1ACB](/claim/clm_828C28EA1ACB.md)
- 2010-07-31 to 2010-10-30 | money | shares_outstanding | 298,089,485 shares | superseded | [clm_F4F98DE38E4A](/claim/clm_F4F98DE38E4A.md)
- 2010-07-31 to 2010-10-30 | money | total_assets | 4,104,068,000 United States dollar | superseded | [clm_2867D914ED30](/claim/clm_2867D914ED30.md)
- 2010-07-31 to 2010-10-30 | money | total_equity | 3,034,475,000 United States dollar | superseded | [clm_1A5E0A2CE91C](/claim/clm_1A5E0A2CE91C.md)
- 2010-10-30 to 2011-01-29 | money | cash_and_equivalents | 1,070,000,000 United States dollar | superseded | [clm_DF2B70849070](/claim/clm_DF2B70849070.md)
- 2010-10-30 to 2011-10-29 | money | net_income | 712,084,000 United States dollar | superseded | [clm_A56E3DAE29DB](/claim/clm_A56E3DAE29DB.md)
- 2010-10-30 to 2011-10-29 | money | operating_income | 900,074,000 United States dollar | superseded | [clm_5A5D06588B36](/claim/clm_5A5D06588B36.md)
- 2010-10-30 to 2011-10-29 | money | research_and_development | 492,305,000 United States dollar | superseded | [clm_6B4D328FDC36](/claim/clm_6B4D328FDC36.md)
- 2010-10-30 to 2011-10-29 | money | revenue | 2,761,503,000 United States dollar | superseded | [clm_11A83786D96F](/claim/clm_11A83786D96F.md)
- 2010-10-30 to 2011-01-29 | money | shares_outstanding | 298,652,994 shares | superseded | [clm_F5D18C2B9BFD](/claim/clm_F5D18C2B9BFD.md)
- 2010-10-30 to 2011-01-29 | money | total_assets | 4,328,831,000 United States dollar | superseded | [clm_199D7CFEA6D0](/claim/clm_199D7CFEA6D0.md)
- 2010-10-30 to 2011-01-29 | money | total_equity | 3,199,717,000 United States dollar | superseded | [clm_7FB09B3E0570](/claim/clm_7FB09B3E0570.md)

## 2011

- 2011-01-29 to 2011-04-30 | money | cash_and_equivalents | 1,570,321,000 United States dollar | superseded | [clm_5D40EF34D8C9](/claim/clm_5D40EF34D8C9.md)
- 2011-01-29 to 2011-04-30 | money | quarterly_net_income | 222,106,000 United States dollar | superseded | [clm_43061FBB748F](/claim/clm_43061FBB748F.md)
- 2011-01-29 to 2011-04-30 | money | quarterly_operating_income | 259,406,000 United States dollar | superseded | [clm_ABAE22A1522A](/claim/clm_ABAE22A1522A.md)
- 2011-01-29 to 2011-04-30 | money | quarterly_research_and_development | 122,745,000 United States dollar | superseded | [clm_7FE92E9EE097](/claim/clm_7FE92E9EE097.md)
- 2011-01-29 to 2011-04-30 | money | quarterly_revenue | 728,504,000 United States dollar | superseded | [clm_F452FBD31B7E](/claim/clm_F452FBD31B7E.md)
- 2011-01-29 to 2011-04-30 | money | shares_outstanding | 299,610,446 shares | superseded | [clm_CA829F3834E6](/claim/clm_CA829F3834E6.md)
- 2011-01-29 to 2011-04-30 | money | total_assets | 4,596,905,000 United States dollar | superseded | [clm_26880CDE9A84](/claim/clm_26880CDE9A84.md)
- 2011-01-29 to 2011-04-30 | money | total_equity | 3,364,427,000 United States dollar | superseded | [clm_980634096B0A](/claim/clm_980634096B0A.md)
- 2011-04-30 to 2011-07-30 | money | cash_and_equivalents | 1,894,761,000 United States dollar | superseded | [clm_24B824024657](/claim/clm_24B824024657.md)
- 2011-04-30 to 2011-07-30 | money | quarterly_net_income | 241,826,000 United States dollar | superseded | [clm_D1780A593589](/claim/clm_D1780A593589.md)
- 2011-04-30 to 2011-07-30 | money | quarterly_operating_income | 298,486,000 United States dollar | superseded | [clm_70763886E8E0](/claim/clm_70763886E8E0.md)
- 2011-04-30 to 2011-07-30 | money | quarterly_research_and_development | 130,460,000 United States dollar | superseded | [clm_D9E2E01E1B37](/claim/clm_D9E2E01E1B37.md)
- 2011-04-30 to 2011-07-30 | money | quarterly_revenue | 790,780,000 United States dollar | superseded | [clm_08CDF1A7C671](/claim/clm_08CDF1A7C671.md)
- 2011-04-30 to 2011-07-30 | money | shares_outstanding | 299,633,520 shares | superseded | [clm_E6138F53ECBF](/claim/clm_E6138F53ECBF.md)
- 2011-04-30 to 2011-07-30 | money | total_assets | 5,160,399,000 United States dollar | superseded | [clm_EAD4BC3208E9](/claim/clm_EAD4BC3208E9.md)
- 2011-04-30 to 2011-07-30 | money | total_equity | 3,581,998,000 United States dollar | superseded | [clm_03CF82BC50F3](/claim/clm_03CF82BC50F3.md)
- 2011-07-30 to 2011-10-29 | money | cash_and_equivalents | 1,357,821,000 United States dollar | superseded | [clm_4DCC1C95C8C7](/claim/clm_4DCC1C95C8C7.md)
- 2011-07-30 to 2012-02-04 | money | quarterly_net_income | 219,935,000 United States dollar | superseded | [clm_55681F35399B](/claim/clm_55681F35399B.md)
- 2011-07-30 to 2012-02-04 | money | quarterly_operating_income | 278,841,000 United States dollar | superseded | [clm_56AE2FE1949D](/claim/clm_56AE2FE1949D.md)
- 2011-07-30 to 2012-02-04 | money | quarterly_research_and_development | 128,476,000 United States dollar | superseded | [clm_C1831ED04C49](/claim/clm_C1831ED04C49.md)
- 2011-07-30 to 2012-02-04 | money | quarterly_revenue | 757,902,000 United States dollar | superseded | [clm_8AE75DBE1EC9](/claim/clm_8AE75DBE1EC9.md)
- 2011-07-30 to 2011-10-29 | money | shares_outstanding | 299,437,920 shares | superseded | [clm_B46927BFBEFD](/claim/clm_B46927BFBEFD.md)
- 2011-07-30 to 2011-10-29 | money | total_assets | 5,251,381,000 United States dollar | superseded | [clm_8160F4A5B0DC](/claim/clm_8160F4A5B0DC.md)
- 2011-07-30 to 2011-10-29 | money | total_equity | 3,715,717,000 United States dollar | superseded | [clm_CD0C54DECDE9](/claim/clm_CD0C54DECDE9.md)
- 2011-10-29 to 2012-02-04 | money | cash_and_equivalents | 1,405,100,000 United States dollar | superseded | [clm_3602EE18C05C](/claim/clm_3602EE18C05C.md)
- 2011-10-29 to 2012-11-03 | money | net_income | 867,394,000 United States dollar | superseded | [clm_EBEA589AD0AF](/claim/clm_EBEA589AD0AF.md)
- 2011-10-29 to 2012-11-03 | money | operating_income | 1,072,025,000 United States dollar | superseded | [clm_1A0B6F3C79EA](/claim/clm_1A0B6F3C79EA.md)
- 2011-10-29 to 2012-11-03 | money | research_and_development | 505,570,000 United States dollar | superseded | [clm_8B420B88DA39](/claim/clm_8B420B88DA39.md)
- 2011-10-29 to 2012-11-03 | money | revenue | 2,993,320,000 United States dollar | superseded | [clm_4CCEE7270F54](/claim/clm_4CCEE7270F54.md)
- 2011-10-29 to 2012-02-04 | money | shares_outstanding | 297,960,718 shares | superseded | [clm_5D3BA7DFBF98](/claim/clm_5D3BA7DFBF98.md)
- 2011-10-29 to 2012-02-04 | money | total_assets | 5,277,635,000 United States dollar | superseded | [clm_40B5EE7DA3C3](/claim/clm_40B5EE7DA3C3.md)
- 2011-10-29 to 2012-02-04 | money | total_equity | 3,795,413,000 United States dollar | superseded | [clm_C9B7DC0C9AD6](/claim/clm_C9B7DC0C9AD6.md)

## 2012

- 2012-02-04 to 2012-05-05 | money | cash_and_equivalents | 1,097,442,000 United States dollar | superseded | [clm_8490C3FD86C6](/claim/clm_8490C3FD86C6.md)
- 2012-02-04 to 2012-05-05 | money | quarterly_net_income | 139,382,000 United States dollar | superseded | [clm_0F7294116580](/claim/clm_0F7294116580.md)
- 2012-02-04 to 2012-05-05 | money | quarterly_operating_income | 183,372,000 United States dollar | superseded | [clm_E36569DE6BD7](/claim/clm_E36569DE6BD7.md)
- 2012-02-04 to 2012-05-05 | money | quarterly_research_and_development | 124,378,000 United States dollar | superseded | [clm_E61D2ED2CD16](/claim/clm_E61D2ED2CD16.md)
- 2012-02-04 to 2012-05-05 | money | quarterly_revenue | 648,058,000 United States dollar | superseded | [clm_B019BA5D76E4](/claim/clm_B019BA5D76E4.md)
- 2012-02-04 to 2012-05-05 | money | shares_outstanding | 297,832,028 shares | superseded | [clm_451BC0A1A466](/claim/clm_451BC0A1A466.md)
- 2012-02-04 to 2012-05-05 | money | total_assets | 5,277,834,000 United States dollar | superseded | [clm_CF74D0BA4212](/claim/clm_CF74D0BA4212.md)
- 2012-02-04 to 2012-05-05 | money | total_equity | 3,842,435,000 United States dollar | superseded | [clm_E7E9BC8843D1](/claim/clm_E7E9BC8843D1.md)
- 2012-05-05 to 2012-08-04 | money | cash_and_equivalents | 695,066,000 United States dollar | superseded | [clm_447014AB9FDF](/claim/clm_447014AB9FDF.md)
- 2012-05-05 to 2012-08-04 | money | quarterly_net_income | 162,899,000 United States dollar | superseded | [clm_70FABD5380C0](/claim/clm_70FABD5380C0.md)
- 2012-05-05 to 2012-08-04 | money | quarterly_operating_income | 212,926,000 United States dollar | superseded | [clm_EA9A7342D972](/claim/clm_EA9A7342D972.md)
- 2012-05-05 to 2012-08-04 | money | quarterly_research_and_development | 127,537,000 United States dollar | superseded | [clm_A55477F723E1](/claim/clm_A55477F723E1.md)
- 2012-05-05 to 2012-08-04 | money | quarterly_revenue | 675,094,000 United States dollar | superseded | [clm_E679F96673C5](/claim/clm_E679F96673C5.md)
- 2012-05-05 to 2012-08-04 | money | shares_outstanding | 298,337,925 shares | superseded | [clm_C95F877C4CBA](/claim/clm_C95F877C4CBA.md)
- 2012-05-05 to 2012-08-04 | money | total_assets | 5,412,490,000 United States dollar | superseded | [clm_8BED4AE444D1](/claim/clm_8BED4AE444D1.md)
- 2012-05-05 to 2012-08-04 | money | total_equity | 3,925,140,000 United States dollar | superseded | [clm_C2A36D5276CE](/claim/clm_C2A36D5276CE.md)
- 2012-08-04 to 2012-11-03 | money | cash_and_equivalents | 462,149,000 United States dollar | superseded | [clm_947C82789DF5](/claim/clm_947C82789DF5.md)
- 2012-08-04 to 2013-02-02 | money | quarterly_net_income | 169,768,000 United States dollar | superseded | [clm_27CF62817133](/claim/clm_27CF62817133.md)
- 2012-08-04 to 2013-02-02 | money | quarterly_operating_income | 212,471,000 United States dollar | superseded | [clm_ABEA9C6C30DF](/claim/clm_ABEA9C6C30DF.md)
- 2012-08-04 to 2013-02-02 | money | quarterly_research_and_development | 129,694,000 United States dollar | superseded | [clm_A5D7EB849105](/claim/clm_A5D7EB849105.md)
- 2012-08-04 to 2013-02-02 | money | quarterly_revenue | 683,026,000 United States dollar | superseded | [clm_2F196448DF12](/claim/clm_2F196448DF12.md)
- 2012-08-04 to 2012-11-03 | money | shares_outstanding | 298,905,593 shares | superseded | [clm_C1AC5CDC9B3B](/claim/clm_C1AC5CDC9B3B.md)
- 2012-08-04 to 2012-11-03 | money | total_assets | 5,456,622,000 United States dollar | superseded | [clm_4EF165C13ACB](/claim/clm_4EF165C13ACB.md)
- 2012-08-04 to 2012-11-03 | money | total_equity | 4,028,606,000 United States dollar | superseded | [clm_D271C97C84FB](/claim/clm_D271C97C84FB.md)
- 2012-11-03 to 2013-02-02 | money | cash_and_equivalents | 528,833,000 United States dollar | superseded | [clm_3DD897EA5D4D](/claim/clm_3DD897EA5D4D.md)
- 2012-11-03 to 2013-11-02 | money | net_income | 651,236,000 United States dollar | superseded | [clm_6D30D1F2713C](/claim/clm_6D30D1F2713C.md)
- 2012-11-03 to 2013-11-02 | money | operating_income | 824,048,000 United States dollar | superseded | [clm_F0DE6B6F3539](/claim/clm_F0DE6B6F3539.md)
- 2012-11-03 to 2013-11-02 | money | research_and_development | 512,003,000 United States dollar | superseded | [clm_EAD368F6D2EE](/claim/clm_EAD368F6D2EE.md)
- 2012-11-03 to 2013-11-02 | money | revenue | 2,701,142,000 United States dollar | superseded | [clm_92FFF005648D](/claim/clm_92FFF005648D.md)
- 2012-11-03 to 2013-02-02 | money | shares_outstanding | 301,389,176 shares | superseded | [clm_9C50AFFBE782](/claim/clm_9C50AFFBE782.md)
- 2012-11-03 to 2013-02-02 | money | total_assets | 5,620,347,000 United States dollar | superseded | [clm_1DA6905D2622](/claim/clm_1DA6905D2622.md)
- 2012-11-03 to 2013-02-02 | money | total_equity | 4,165,359,000 United States dollar | superseded | [clm_5FD361D19AB5](/claim/clm_5FD361D19AB5.md)

## 2013

- 2013-02-02 to 2013-05-04 | money | cash_and_equivalents | 795,797,000 United States dollar | superseded | [clm_35015922579D](/claim/clm_35015922579D.md)
- 2013-02-02 to 2013-05-04 | money | quarterly_net_income | 131,222,000 United States dollar | superseded | [clm_3A0C15A22F30](/claim/clm_3A0C15A22F30.md)
- 2013-02-02 to 2013-05-04 | money | quarterly_operating_income | 153,489,000 United States dollar | superseded | [clm_AD2924BC3AD6](/claim/clm_AD2924BC3AD6.md)
- 2013-02-02 to 2013-05-04 | money | quarterly_research_and_development | 125,164,000 United States dollar | superseded | [clm_E5C878139C90](/claim/clm_E5C878139C90.md)
- 2013-02-02 to 2013-05-04 | money | quarterly_revenue | 622,134,000 United States dollar | superseded | [clm_B05C7833886F](/claim/clm_B05C7833886F.md)
- 2013-02-02 to 2013-05-04 | money | shares_outstanding | 305,984,586 shares | superseded | [clm_830EE76B550A](/claim/clm_830EE76B550A.md)
- 2013-02-02 to 2013-05-04 | money | total_assets | 5,716,808,000 United States dollar | superseded | [clm_80C584725C07](/claim/clm_80C584725C07.md)
- 2013-02-02 to 2013-05-04 | money | total_equity | 4,323,797,000 United States dollar | superseded | [clm_E806A7AEC6A4](/claim/clm_E806A7AEC6A4.md)
- 2013-05-04 to 2013-08-03 | money | cash_and_equivalents | 595,631,000 United States dollar | superseded | [clm_E4271A6BF55C](/claim/clm_E4271A6BF55C.md)
- 2013-05-04 to 2013-08-03 | money | quarterly_net_income | 164,472,000 United States dollar | superseded | [clm_529E2FE62DDD](/claim/clm_529E2FE62DDD.md)
- 2013-05-04 to 2013-08-03 | money | quarterly_operating_income | 191,382,000 United States dollar | superseded | [clm_359E5936C5ED](/claim/clm_359E5936C5ED.md)
- 2013-05-04 to 2013-08-03 | money | quarterly_research_and_development | 128,110,000 United States dollar | superseded | [clm_5BE22A49BAA0](/claim/clm_5BE22A49BAA0.md)
- 2013-05-04 to 2013-08-03 | money | quarterly_revenue | 659,250,000 United States dollar | superseded | [clm_359981E3A92E](/claim/clm_359981E3A92E.md)
- 2013-05-04 to 2013-08-03 | money | shares_outstanding | 308,165,416 shares | superseded | [clm_773D416E25C3](/claim/clm_773D416E25C3.md)
- 2013-05-04 to 2013-08-03 | money | total_assets | 5,841,036,000 United States dollar | superseded | [clm_D78D3BFDF66F](/claim/clm_D78D3BFDF66F.md)
- 2013-05-04 to 2013-08-03 | money | total_equity | 4,460,590,000 United States dollar | superseded | [clm_4A6302034724](/claim/clm_4A6302034724.md)
- 2013-08-03 to 2013-11-02 | money | cash_and_equivalents | 460,068,000 United States dollar | superseded | [clm_19DBB3D927C4](/claim/clm_19DBB3D927C4.md)
- 2013-08-03 to 2014-02-01 | money | quarterly_net_income | 176,239,000 United States dollar | superseded | [clm_AC35C0FC5206](/claim/clm_AC35C0FC5206.md)
- 2013-08-03 to 2014-02-01 | money | quarterly_operating_income | 208,342,000 United States dollar | superseded | [clm_4F846E14DB94](/claim/clm_4F846E14DB94.md)
- 2013-08-03 to 2014-02-01 | money | quarterly_research_and_development | 128,947,000 United States dollar | superseded | [clm_F68A4626F8ED](/claim/clm_F68A4626F8ED.md)
- 2013-08-03 to 2014-02-01 | money | quarterly_revenue | 674,172,000 United States dollar | superseded | [clm_500691E7AFE2](/claim/clm_500691E7AFE2.md)
- 2013-08-03 to 2013-11-02 | money | shares_outstanding | 310,692,734 shares | superseded | [clm_7102059291ED](/claim/clm_7102059291ED.md)
- 2013-08-03 to 2013-11-02 | money | total_assets | 6,138,626,000 United States dollar | superseded | [clm_415534563093](/claim/clm_415534563093.md)
- 2013-08-03 to 2013-11-02 | money | total_equity | 4,643,236,000 United States dollar | superseded | [clm_18CCBB59331C](/claim/clm_18CCBB59331C.md)
- 2013-11-02 to 2014-02-01 | money | cash_and_equivalents | 392,089,000 United States dollar | superseded | [clm_3E7AD5CC4692](/claim/clm_3E7AD5CC4692.md)
- 2013-11-02 to 2014-11-01 | money | net_income | 673,487,000 United States dollar | superseded | [clm_53BB2894EAD4](/claim/clm_53BB2894EAD4.md)
- 2013-11-02 to 2014-11-01 | money | operating_income | 753,075,000 United States dollar | superseded | [clm_90450D0ED6F5](/claim/clm_90450D0ED6F5.md)
- 2013-11-02 to 2014-11-01 | money | research_and_development | 513,255,000 United States dollar | superseded | [clm_3C5DE92AB778](/claim/clm_3C5DE92AB778.md)
- 2013-11-02 to 2014-11-01 | money | revenue | 2,633,689,000 United States dollar | superseded | [clm_233B9E007430](/claim/clm_233B9E007430.md)
- 2013-11-02 to 2014-02-01 | money | shares_outstanding | 311,045,084 shares | superseded | [clm_4D43A9316372](/claim/clm_4D43A9316372.md)
- 2013-11-02 to 2014-02-01 | money | total_assets | 6,381,750,000 United States dollar | superseded | [clm_6F1C63F22EEB](/claim/clm_6F1C63F22EEB.md)
- 2013-11-02 to 2014-02-01 | money | total_equity | 4,739,576,000 United States dollar | superseded | [clm_758B600C96D5](/claim/clm_758B600C96D5.md)

## 2014

- 2014-02-01 to 2014-05-03 | money | cash_and_equivalents | 417,227,000 United States dollar | superseded | [clm_C8FD95D5DB63](/claim/clm_C8FD95D5DB63.md)
- 2014-02-01 to 2014-05-03 | money | quarterly_net_income | 152,586,000 United States dollar | superseded | [clm_BF51EFA5435D](/claim/clm_BF51EFA5435D.md)
- 2014-02-01 to 2014-05-03 | money | quarterly_operating_income | 179,609,000 United States dollar | superseded | [clm_3C2688F388EF](/claim/clm_3C2688F388EF.md)
- 2014-02-01 to 2014-05-03 | money | quarterly_research_and_development | 128,646,000 United States dollar | superseded | [clm_99A7E608B6CB](/claim/clm_99A7E608B6CB.md)
- 2014-02-01 to 2014-05-03 | money | quarterly_revenue | 628,238,000 United States dollar | superseded | [clm_969BB6A02070](/claim/clm_969BB6A02070.md)
- 2014-02-01 to 2014-05-03 | money | shares_outstanding | 312,527,904 shares | superseded | [clm_6C505222F3E2](/claim/clm_6C505222F3E2.md)
- 2014-02-01 to 2014-05-03 | money | total_assets | 6,399,468,000 United States dollar | superseded | [clm_6D60D0022B83](/claim/clm_6D60D0022B83.md)
- 2014-02-01 to 2014-05-03 | money | total_equity | 4,795,635,000 United States dollar | superseded | [clm_9A4B3D02C784](/claim/clm_9A4B3D02C784.md)
- 2014-05-03 to 2014-08-02 | money | cash_and_equivalents | 402,790,000 United States dollar | superseded | [clm_8B32D5B05BF8](/claim/clm_8B32D5B05BF8.md)
- 2014-05-03 to 2014-08-02 | money | quarterly_net_income | 187,433,000 United States dollar | superseded | [clm_D854CB9D7466](/claim/clm_D854CB9D7466.md)
- 2014-05-03 to 2014-08-02 | money | quarterly_operating_income | 220,400,000 United States dollar | superseded | [clm_47DB8B14606C](/claim/clm_47DB8B14606C.md)
- 2014-05-03 to 2014-08-02 | money | quarterly_research_and_development | 136,258,000 United States dollar | superseded | [clm_C4C0744C931F](/claim/clm_C4C0744C931F.md)
- 2014-05-03 to 2014-08-02 | money | quarterly_revenue | 694,536,000 United States dollar | superseded | [clm_FA4CCEF1C8C9](/claim/clm_FA4CCEF1C8C9.md)
- 2014-05-03 to 2014-08-02 | money | shares_outstanding | 314,145,403 shares | superseded | [clm_3FFDAAC803BF](/claim/clm_3FFDAAC803BF.md)
- 2014-05-03 to 2014-08-02 | money | total_assets | 6,594,951,000 United States dollar | superseded | [clm_D29B81214430](/claim/clm_D29B81214430.md)
- 2014-05-03 to 2014-08-02 | money | total_equity | 4,931,523,000 United States dollar | superseded | [clm_F5337C713AF5](/claim/clm_F5337C713AF5.md)
- 2014-08-02 to 2014-11-01 | money | cash_and_equivalents | 2,585,441,000 United States dollar | superseded | [clm_868518B6194A](/claim/clm_868518B6194A.md)
- 2014-08-02 to 2015-01-31 | money | quarterly_net_income | 180,606,000 United States dollar | superseded | [clm_CFBF5B9C8117](/claim/clm_CFBF5B9C8117.md)
- 2014-08-02 to 2015-01-31 | money | quarterly_operating_income | 202,546,000 United States dollar | superseded | [clm_F4FCFB3AE5E7](/claim/clm_F4FCFB3AE5E7.md)
- 2014-08-02 to 2015-01-31 | money | quarterly_research_and_development | 140,095,000 United States dollar | superseded | [clm_E3591C4415CC](/claim/clm_E3591C4415CC.md)
- 2014-08-02 to 2015-01-31 | money | quarterly_revenue | 727,752,000 United States dollar | superseded | [clm_809EF00E4A1B](/claim/clm_809EF00E4A1B.md)
- 2014-08-02 to 2014-11-01 | money | shares_outstanding | 314,212,784 shares | superseded | [clm_E836110274F7](/claim/clm_E836110274F7.md)
- 2014-08-02 to 2014-11-01 | money | total_assets | 8,973,465,000 United States dollar | superseded | [clm_791BF54B5D49](/claim/clm_791BF54B5D49.md)
- 2014-08-02 to 2014-11-01 | money | total_equity | 5,007,197,000 United States dollar | superseded | [clm_0C3F90126985](/claim/clm_0C3F90126985.md)
- 2014-11-01 to 2015-01-31 | money | cash_and_equivalents | 569,233,000 United States dollar | superseded | [clm_23A9593D788D](/claim/clm_23A9593D788D.md)
- 2014-11-01 to 2015-10-31 | money | net_income | 629,320,000 United States dollar | superseded | [clm_92866E8638E4](/claim/clm_92866E8638E4.md)
- 2014-11-01 to 2015-10-31 | money | operating_income | 752,484,000 United States dollar | superseded | [clm_77CC5490B916](/claim/clm_77CC5490B916.md)
- 2014-11-01 to 2015-10-31 | money | research_and_development | 559,686,000 United States dollar | superseded | [clm_E60F58905D3C](/claim/clm_E60F58905D3C.md)
- 2014-11-01 to 2015-10-31 | money | revenue | 2,864,773,000 United States dollar | superseded | [clm_7C6FA8255802](/claim/clm_7C6FA8255802.md)
- 2014-11-01 to 2015-01-31 | money | shares_outstanding | 311,204,926 shares | superseded | [clm_87CF118FF9D0](/claim/clm_87CF118FF9D0.md)
- 2014-11-01 to 2015-01-31 | money | total_assets | 6,859,690,000 United States dollar | superseded | [clm_D82F4A2805CB](/claim/clm_D82F4A2805CB.md)
- 2014-11-01 to 2015-01-31 | money | total_equity | 4,757,897,000 United States dollar | superseded | [clm_237D61F42C98](/claim/clm_237D61F42C98.md)

## 2015

- 2015-01-31 to 2015-05-02 | money | cash_and_equivalents | 650,202,000 United States dollar | superseded | [clm_D49EC25D12B5](/claim/clm_D49EC25D12B5.md)
- 2015-01-31 to 2015-05-02 | money | quarterly_net_income | 178,757,000 United States dollar | superseded | [clm_3EE335F91699](/claim/clm_3EE335F91699.md)
- 2015-01-31 to 2015-05-02 | money | quarterly_operating_income | 207,934,000 United States dollar | superseded | [clm_50E35D250C45](/claim/clm_50E35D250C45.md)
- 2015-01-31 to 2015-05-02 | money | quarterly_research_and_development | 151,706,000 United States dollar | superseded | [clm_27754CADE305](/claim/clm_27754CADE305.md)
- 2015-01-31 to 2015-05-02 | money | quarterly_revenue | 771,986,000 United States dollar | superseded | [clm_7046E0F8C03A](/claim/clm_7046E0F8C03A.md)
- 2015-01-31 to 2015-05-02 | money | shares_outstanding | 311,627,385 shares | superseded | [clm_29E63A81E01B](/claim/clm_29E63A81E01B.md)
- 2015-01-31 to 2015-05-02 | money | total_assets | 6,821,156,000 United States dollar | superseded | [clm_80290E728665](/claim/clm_80290E728665.md)
- 2015-01-31 to 2015-05-02 | money | total_equity | 4,806,210,000 United States dollar | superseded | [clm_57A2FC1091A7](/claim/clm_57A2FC1091A7.md)
- 2015-05-02 to 2015-08-01 | money | cash_and_equivalents | 636,216,000 United States dollar | superseded | [clm_A214EAA9A99B](/claim/clm_A214EAA9A99B.md)
- 2015-05-02 to 2015-08-01 | money | quarterly_net_income | 205,338,000 United States dollar | superseded | [clm_387091E0DAD3](/claim/clm_387091E0DAD3.md)
- 2015-05-02 to 2015-08-01 | money | quarterly_operating_income | 249,008,000 United States dollar | superseded | [clm_E66B54C47003](/claim/clm_E66B54C47003.md)
- 2015-05-02 to 2015-08-01 | money | quarterly_research_and_development | 154,233,000 United States dollar | superseded | [clm_17653763A9B2](/claim/clm_17653763A9B2.md)
- 2015-05-02 to 2015-08-01 | money | quarterly_revenue | 821,019,000 United States dollar | superseded | [clm_FF5F4834FE7C](/claim/clm_FF5F4834FE7C.md)
- 2015-05-02 to 2015-08-01 | money | shares_outstanding | 313,541,685 shares | superseded | [clm_4066AED91CA2](/claim/clm_4066AED91CA2.md)
- 2015-05-02 to 2015-08-01 | money | total_assets | 7,048,475,000 United States dollar | superseded | [clm_EF0FCAD647D9](/claim/clm_EF0FCAD647D9.md)
- 2015-05-02 to 2015-08-01 | money | total_equity | 4,964,208,000 United States dollar | superseded | [clm_DE083327D383](/claim/clm_DE083327D383.md)
- 2015-08-01 to 2015-10-31 | money | cash_and_equivalents | 557,497,000 United States dollar | superseded | [clm_2316F74C8CBA](/claim/clm_2316F74C8CBA.md)
- 2015-08-01 to 2016-01-30 | money | quarterly_net_income | 216,478,000 United States dollar | superseded | [clm_156410FAEC26](/claim/clm_156410FAEC26.md)
- 2015-08-01 to 2016-01-30 | money | quarterly_operating_income | 265,269,000 United States dollar | superseded | [clm_218AC36D101E](/claim/clm_218AC36D101E.md)
- 2015-08-01 to 2016-01-30 | money | quarterly_research_and_development | 160,784,000 United States dollar | superseded | [clm_15D52A647B38](/claim/clm_15D52A647B38.md)
- 2015-08-01 to 2016-01-30 | money | quarterly_revenue | 863,365,000 United States dollar | superseded | [clm_CC2268F539E5](/claim/clm_CC2268F539E5.md)
- 2015-08-01 to 2015-10-31 | money | shares_outstanding | 313,674,772 shares | superseded | [clm_40FAF3F53140](/claim/clm_40FAF3F53140.md)
- 2015-08-01 to 2015-10-31 | money | total_assets | 7,134,701,000 United States dollar | superseded | [clm_5DAAA50E2FB4](/claim/clm_5DAAA50E2FB4.md)
- 2015-08-01 to 2015-10-31 | money | total_equity | 5,065,161,000 United States dollar | superseded | [clm_216D54FD6B30](/claim/clm_216D54FD6B30.md)
- 2015-10-31 to 2016-01-30 | money | cash_and_equivalents | 884,353,000 United States dollar | superseded | [clm_BA83275F8D9D](/claim/clm_BA83275F8D9D.md)
- 2015-10-31 to 2016-10-29 | money | net_income | 696,878,000 United States dollar | superseded | [clm_12EE8D99E5E7](/claim/clm_12EE8D99E5E7.md)
- 2015-10-31 to 2016-10-29 | money | operating_income | 830,841,000 United States dollar | superseded | [clm_D8E0A9621785](/claim/clm_D8E0A9621785.md)
- 2015-10-31 to 2016-10-29 | money | research_and_development | 637,459,000 United States dollar | superseded | [clm_F2F882CE8B15](/claim/clm_F2F882CE8B15.md)
- 2015-10-31 to 2016-10-29 | money | revenue | 3,435,092,000 United States dollar | superseded | [clm_7D62D1681F7C](/claim/clm_7D62D1681F7C.md)
- 2015-10-31 to 2016-01-30 | money | shares_outstanding | 312,060,682 shares | superseded | [clm_7F858732AC83](/claim/clm_7F858732AC83.md)
- 2015-10-31 to 2016-01-30 | money | total_assets | 7,062,178,000 United States dollar | superseded | [clm_6B3E38EB1373](/claim/clm_6B3E38EB1373.md)
- 2015-10-31 to 2016-01-30 | money | total_equity | 5,072,959,000 United States dollar | superseded | [clm_61B61BA404AA](/claim/clm_61B61BA404AA.md)

## 2016

- 2016-01-30 to 2016-04-30 | money | cash_and_equivalents | 1,470,442,000 United States dollar | superseded | [clm_FDEEBA2100EB](/claim/clm_FDEEBA2100EB.md)
- 2016-01-30 to 2016-04-30 | money | quarterly_net_income | 164,504,000 United States dollar | superseded | [clm_F5783E63CB49](/claim/clm_F5783E63CB49.md)
- 2016-01-30 to 2016-04-30 | money | quarterly_operating_income | 195,045,000 United States dollar | superseded | [clm_EB2F31C64590](/claim/clm_EB2F31C64590.md)
- 2016-01-30 to 2016-04-30 | money | quarterly_research_and_development | 157,428,000 United States dollar | superseded | [clm_F40B0F85A725](/claim/clm_F40B0F85A725.md)
- 2016-01-30 to 2016-04-30 | money | quarterly_revenue | 769,429,000 United States dollar | superseded | [clm_135A6707B282](/claim/clm_135A6707B282.md)
- 2016-01-30 to 2016-04-30 | money | shares_outstanding | 310,019,122 shares | superseded | [clm_65C767F0B4D2](/claim/clm_65C767F0B4D2.md)
- 2016-01-30 to 2016-04-30 | money | total_assets | 7,598,081,000 United States dollar | superseded | [clm_02CF06AAB308](/claim/clm_02CF06AAB308.md)
- 2016-01-30 to 2016-04-30 | money | total_equity | 4,994,862,000 United States dollar | superseded | [clm_DF4E8F176D0A](/claim/clm_DF4E8F176D0A.md)
- 2016-04-30 to 2016-07-30 | money | cash_and_equivalents | 1,119,662,000 United States dollar | superseded | [clm_AE04BEC7263B](/claim/clm_AE04BEC7263B.md)
- 2016-04-30 to 2016-07-30 | money | quarterly_net_income | 170,573,000 United States dollar | superseded | [clm_E1F75FDBB6AA](/claim/clm_E1F75FDBB6AA.md)
- 2016-04-30 to 2016-07-30 | money | quarterly_operating_income | 207,379,000 United States dollar | superseded | [clm_52C7BAEC39C1](/claim/clm_52C7BAEC39C1.md)
- 2016-04-30 to 2016-07-30 | money | quarterly_research_and_development | 160,235,000 United States dollar | superseded | [clm_476657357EE0](/claim/clm_476657357EE0.md)
- 2016-04-30 to 2016-07-30 | money | quarterly_revenue | 778,766,000 United States dollar | superseded | [clm_EFED94FA4400](/claim/clm_EFED94FA4400.md)
- 2016-04-30 to 2016-07-30 | money | shares_outstanding | 307,349,804 shares | superseded | [clm_71AC10D0A2FD](/claim/clm_71AC10D0A2FD.md)
- 2016-04-30 to 2016-07-30 | money | total_assets | 7,570,292,000 United States dollar | superseded | [clm_45ACC06B3590](/claim/clm_45ACC06B3590.md)
- 2016-04-30 to 2016-07-30 | money | total_equity | 4,873,701,000 United States dollar | superseded | [clm_48930755DF12](/claim/clm_48930755DF12.md)
- 2016-07-30 to 2016-10-29 | money | cash_and_equivalents | 1,103,670,000 United States dollar | superseded | [clm_7A35669A9273](/claim/clm_7A35669A9273.md)
- 2016-07-30 to 2017-01-28 | money | quarterly_net_income | 230,430,000 United States dollar | superseded | [clm_C5AF83B056A2](/claim/clm_C5AF83B056A2.md)
- 2016-07-30 to 2017-01-28 | money | quarterly_operating_income | 268,707,000 United States dollar | superseded | [clm_3A6CA91E2CBC](/claim/clm_3A6CA91E2CBC.md)
- 2016-07-30 to 2017-01-28 | money | quarterly_research_and_development | 163,227,000 United States dollar | superseded | [clm_5714656DCDB3](/claim/clm_5714656DCDB3.md)
- 2016-07-30 to 2017-01-28 | money | quarterly_revenue | 869,591,000 United States dollar | superseded | [clm_013E8DBE9799](/claim/clm_013E8DBE9799.md)
- 2016-07-30 to 2016-10-29 | money | shares_outstanding | 307,474,197 shares | superseded | [clm_56C0DF8C2CE2](/claim/clm_56C0DF8C2CE2.md)
- 2016-07-30 to 2016-10-29 | money | total_assets | 7,685,053,000 United States dollar | superseded | [clm_0596852D3965](/claim/clm_0596852D3965.md)
- 2016-07-30 to 2016-10-29 | money | total_equity | 4,983,333,000 United States dollar | superseded | [clm_030E2770F133](/claim/clm_030E2770F133.md)
- 2016-10-29 to 2017-01-28 | money | cash_and_equivalents | 921,132,000 United States dollar | superseded | [clm_EE2A87567EB0](/claim/clm_EE2A87567EB0.md)
- 2016-10-29 to 2017-10-28 | money | net_income | 861,664,000 United States dollar | superseded | [clm_D90BBF475F56](/claim/clm_D90BBF475F56.md)
- 2016-10-29 to 2017-10-28 | money | operating_income | 1,028,112,000 United States dollar | superseded | [clm_FDEF3C8B57F8](/claim/clm_FDEF3C8B57F8.md)
- 2016-10-29 to 2017-10-28 | money | research_and_development | 653,816,000 United States dollar | superseded | [clm_47E0FE5A5569](/claim/clm_47E0FE5A5569.md)
- 2016-10-29 to 2017-10-28 | money | revenue | 3,421,409,000 United States dollar | superseded | [clm_1B5EAD110AE9](/claim/clm_1B5EAD110AE9.md)
- 2016-10-29 to 2017-01-28 | money | shares_outstanding | 308,170,560 shares | superseded | [clm_9C074E395DB3](/claim/clm_9C074E395DB3.md)
- 2016-10-29 to 2017-01-28 | money | total_assets | 7,970,278,000 United States dollar | superseded | [clm_64F8C57B64F9](/claim/clm_64F8C57B64F9.md)
- 2016-10-29 to 2017-01-28 | money | total_equity | 5,165,618,000 United States dollar | superseded | [clm_829BD5BB1BB8](/claim/clm_829BD5BB1BB8.md)

## 2017

- 2017-01-28 to 2017-04-29 | money | cash_and_equivalents | 4,987,263,000 United States dollar | superseded | [clm_3A2FCA204B28](/claim/clm_3A2FCA204B28.md)
- 2017-01-28 to 2017-04-29 | money | quarterly_net_income | 217,129,000 United States dollar | superseded | [clm_362672527C9E](/claim/clm_362672527C9E.md)
- 2017-01-28 to 2017-04-29 | money | quarterly_operating_income | 266,268,000 United States dollar | superseded | [clm_58BB8F3E5F6B](/claim/clm_58BB8F3E5F6B.md)
- 2017-01-28 to 2017-04-29 | money | quarterly_research_and_development | 183,954,000 United States dollar | superseded | [clm_B69DED7CFA0A](/claim/clm_B69DED7CFA0A.md)
- 2017-01-28 to 2017-04-29 | money | quarterly_revenue | 984,449,000 United States dollar | superseded | [clm_85A9717146EF](/claim/clm_85A9717146EF.md)
- 2017-01-28 to 2017-04-29 | money | shares_outstanding | 309,206,677 shares | superseded | [clm_BC56C6C9E2C6](/claim/clm_BC56C6C9E2C6.md)
- 2017-01-28 to 2017-04-29 | money | total_assets | 10,203,371,000 United States dollar | superseded | [clm_041A32BC928A](/claim/clm_041A32BC928A.md)
- 2017-01-28 to 2017-04-29 | money | total_equity | 5,306,431,000 United States dollar | superseded | [clm_6830FEBDCC75](/claim/clm_6830FEBDCC75.md)
- 2017-04-29 to 2017-07-29 | money | cash_and_equivalents | 5,697,743,000 United States dollar | superseded | [clm_80E5CF24E1E6](/claim/clm_80E5CF24E1E6.md)
- 2017-04-29 to 2017-07-29 | money | quarterly_net_income | 93,564,000 United States dollar | superseded | [clm_8A7235B4AE04](/claim/clm_8A7235B4AE04.md)
- 2017-04-29 to 2017-07-29 | money | quarterly_operating_income | 145,835,000 United States dollar | superseded | [clm_34D6ED5D3360](/claim/clm_34D6ED5D3360.md)
- 2017-04-29 to 2017-07-29 | money | quarterly_research_and_development | 235,232,000 United States dollar | superseded | [clm_0CC8AAC51782](/claim/clm_0CC8AAC51782.md)
- 2017-04-29 to 2017-07-29 | money | quarterly_revenue | 1,147,982,000 United States dollar | superseded | [clm_DD3197B4DB06](/claim/clm_DD3197B4DB06.md)
- 2017-04-29 to 2017-07-29 | money | shares_outstanding | 367,011,463 shares | superseded | [clm_5DD3C43C9779](/claim/clm_5DD3C43C9779.md)
- 2017-04-29 to 2017-07-29 | money | total_assets | 26,622,683,000 United States dollar | superseded | [clm_7E76E20CB581](/claim/clm_7E76E20CB581.md)
- 2017-04-29 to 2017-07-29 | money | total_equity | 9,966,595,000 United States dollar | superseded | [clm_8E4F98189E63](/claim/clm_8E4F98189E63.md)
- 2017-07-29 to 2017-10-28 | money | cash_and_equivalents | 908,569,000 United States dollar | superseded | [clm_29001527622E](/claim/clm_29001527622E.md)
- 2017-07-29 to 2018-02-03 | money | quarterly_net_income | 68,916,000 United States dollar | superseded | [clm_3A54A2179ED2](/claim/clm_3A54A2179ED2.md)
- 2017-07-29 to 2018-02-03 | money | quarterly_operating_income | 194,821,000 United States dollar | superseded | [clm_32357C9E58C9](/claim/clm_32357C9E58C9.md)
- 2017-07-29 to 2018-02-03 | money | quarterly_research_and_development | 275,670,000 United States dollar | superseded | [clm_A8881421770C](/claim/clm_A8881421770C.md)
- 2017-07-29 to 2018-02-03 | money | quarterly_revenue | 1,433,902,000 United States dollar | superseded | [clm_5582EC0D34B1](/claim/clm_5582EC0D34B1.md)
- 2017-07-29 to 2017-10-28 | money | shares_outstanding | 367,667,745 shares | superseded | [clm_25DB0BC3B3EE](/claim/clm_25DB0BC3B3EE.md)
- 2017-07-29 to 2017-10-28 | money | total_assets | 21,114,995,000 United States dollar | superseded | [clm_717EDD51F82D](/claim/clm_717EDD51F82D.md)
- 2017-07-29 to 2017-10-28 | money | total_equity | 9,922,900,000 United States dollar | superseded | [clm_F4D92C55338D](/claim/clm_F4D92C55338D.md)
- 2017-10-28 to 2018-02-03 | money | cash_and_equivalents | 1,047,838,000 United States dollar | superseded | [clm_B6ABE43E0CF7](/claim/clm_B6ABE43E0CF7.md)
- 2017-10-28 to 2018-11-03 | money | net_income | 727,259,000 United States dollar | superseded | [clm_5A9BA695DEB1](/claim/clm_5A9BA695DEB1.md)
- 2017-10-28 to 2018-11-03 | money | operating_income | 1,055,134,000 United States dollar | superseded | [clm_E920C294DDEF](/claim/clm_E920C294DDEF.md)
- 2017-10-28 to 2018-11-03 | money | research_and_development | 968,602,000 United States dollar | superseded | [clm_2AEB97B4FC9D](/claim/clm_2AEB97B4FC9D.md)
- 2017-10-28 to 2018-11-03 | money | revenue | 5,107,503,000 United States dollar | superseded | [clm_F4FE67F72ADB](/claim/clm_F4FE67F72ADB.md)
- 2017-10-28 to 2018-02-03 | money | shares_outstanding | 368,635,788 shares | superseded | [clm_3AE64B5593A7](/claim/clm_3AE64B5593A7.md)
- 2017-10-28 to 2018-02-03 | money | total_assets | 21,141,294,000 United States dollar | superseded | [clm_AC7E3DAEEA41](/claim/clm_AC7E3DAEEA41.md)
- 2017-10-28 to 2018-02-03 | money | total_equity | 10,161,540,000 United States dollar | superseded | [clm_E614BC5FBFEC](/claim/clm_E614BC5FBFEC.md)

## 2018

- 2018-02-03 to 2018-05-05 | money | cash_and_equivalents | 827,550,000 United States dollar | superseded | [clm_D96D5BCFB207](/claim/clm_D96D5BCFB207.md)
- 2018-02-03 to 2018-05-05 | money | quarterly_net_income | 268,172,000 United States dollar | superseded | [clm_13991AB2B7FF](/claim/clm_13991AB2B7FF.md)
- 2018-02-03 to 2018-05-05 | money | quarterly_operating_income | 405,348,000 United States dollar | superseded | [clm_D4B52EB949A3](/claim/clm_D4B52EB949A3.md)
- 2018-02-03 to 2018-05-05 | money | quarterly_research_and_development | 288,597,000 United States dollar | superseded | [clm_32DCB0378E13](/claim/clm_32DCB0378E13.md)
- 2018-02-03 to 2018-05-05 | money | quarterly_revenue | 1,566,870,000 United States dollar | superseded | [clm_8E1BA4598EC8](/claim/clm_8E1BA4598EC8.md)
- 2018-02-03 to 2018-05-05 | money | shares_outstanding | 369,803,589 shares | superseded | [clm_C5D53D976AEB](/claim/clm_C5D53D976AEB.md)
- 2018-02-03 to 2018-05-05 | money | total_assets | 20,853,315,000 United States dollar | superseded | [clm_FD7EDE257D05](/claim/clm_FD7EDE257D05.md)
- 2018-02-03 to 2018-05-05 | money | total_equity | 10,347,779,000 United States dollar | superseded | [clm_EAA656E9C10D](/claim/clm_EAA656E9C10D.md)
- 2018-05-05 to 2018-08-04 | money | cash_and_equivalents | 806,517,000 United States dollar | superseded | [clm_CE704DD3CEAF](/claim/clm_CE704DD3CEAF.md)
- 2018-05-05 to 2018-08-04 | money | quarterly_net_income | 379,831,000 United States dollar | superseded | [clm_C0CAD6B3E5FF](/claim/clm_C0CAD6B3E5FF.md)
- 2018-05-05 to 2018-08-04 | money | quarterly_operating_income | 463,976,000 United States dollar | superseded | [clm_0A905E52E06C](/claim/clm_0A905E52E06C.md)
- 2018-05-05 to 2018-08-04 | money | quarterly_research_and_development | 289,472,000 United States dollar | superseded | [clm_B1893BB8C3FE](/claim/clm_B1893BB8C3FE.md)
- 2018-05-05 to 2018-08-04 | money | quarterly_revenue | 1,563,502,000 United States dollar | superseded | [clm_D4192DF607CA](/claim/clm_D4192DF607CA.md)
- 2018-05-05 to 2018-08-04 | money | shares_outstanding | 370,897,292 shares | superseded | [clm_9823D435BF69](/claim/clm_9823D435BF69.md)
- 2018-05-05 to 2018-08-04 | money | total_assets | 20,776,454,000 United States dollar | superseded | [clm_FBC74931BC78](/claim/clm_FBC74931BC78.md)
- 2018-05-05 to 2018-08-04 | money | total_equity | 10,585,355,000 United States dollar | superseded | [clm_28EB0C4A7F7C](/claim/clm_28EB0C4A7F7C.md)
- 2018-08-04 to 2018-11-03 | money | cash_and_equivalents | 772,575,000 United States dollar | superseded | [clm_CB1AF0C7B9BD](/claim/clm_CB1AF0C7B9BD.md)
- 2018-08-04 to 2019-02-02 | money | quarterly_net_income | 414,464,000 United States dollar | superseded | [clm_8A64F86C5AEE](/claim/clm_8A64F86C5AEE.md)
- 2018-08-04 to 2019-02-02 | money | quarterly_operating_income | 499,039,000 United States dollar | superseded | [clm_BBE79371552A](/claim/clm_BBE79371552A.md)
- 2018-08-04 to 2019-02-02 | money | quarterly_research_and_development | 291,642,000 United States dollar | superseded | [clm_90C531DA4AA0](/claim/clm_90C531DA4AA0.md)
- 2018-08-04 to 2019-02-02 | money | quarterly_revenue | 1,572,679,000 United States dollar | superseded | [clm_B7E9C9B7338E](/claim/clm_B7E9C9B7338E.md)
- 2018-08-04 to 2018-11-03 | money | shares_outstanding | 371,669,966 shares | superseded | [clm_51CE8FB86715](/claim/clm_51CE8FB86715.md)
- 2018-08-04 to 2018-11-03 | money | total_assets | 20,548,616,000 United States dollar | superseded | [clm_9F7FCBC62700](/claim/clm_9F7FCBC62700.md)
- 2018-08-04 to 2018-11-03 | money | total_equity | 10,856,217,000 United States dollar | superseded | [clm_1BAE6BF198A2](/claim/clm_1BAE6BF198A2.md)
- 2018-11-03 to 2019-02-02 | money | cash_and_equivalents | 816,591,000 United States dollar | superseded | [clm_77B9DE148D32](/claim/clm_77B9DE148D32.md)
- 2018-11-03 to 2019-11-02 | money | net_income | 1,495,432,000 United States dollar | superseded | [clm_AB83F612C1CD](/claim/clm_AB83F612C1CD.md)
- 2018-11-03 to 2019-11-02 | money | operating_income | 1,881,735,000 United States dollar | superseded | [clm_9032CFC7A802](/claim/clm_9032CFC7A802.md)
- 2018-11-03 to 2019-11-02 | money | research_and_development | 1,165,410,000 United States dollar | superseded | [clm_121896F7EACE](/claim/clm_121896F7EACE.md)
- 2018-11-03 to 2019-11-02 | money | revenue | 6,200,942,000 United States dollar | superseded | [clm_D90DE9BC90CE](/claim/clm_D90DE9BC90CE.md)
- 2018-11-03 to 2019-02-02 | money | shares_outstanding | 370,159,553 shares | superseded | [clm_0B17B879F10E](/claim/clm_0B17B879F10E.md)
- 2018-11-03 to 2019-02-02 | money | total_assets | 20,449,779,000 United States dollar | superseded | [clm_EEA74144189F](/claim/clm_EEA74144189F.md)
- 2018-11-03 to 2019-02-02 | money | total_equity | 10,988,540,000 United States dollar | superseded | [clm_66699D20C8D4](/claim/clm_66699D20C8D4.md)

## 2019

- 2019-02-02 to 2019-05-04 | money | cash_and_equivalents | 605,864,000 United States dollar | superseded | [clm_5BDD15766442](/claim/clm_5BDD15766442.md)
- 2019-02-02 to 2019-05-04 | money | quarterly_net_income | 355,006,000 United States dollar | superseded | [clm_F6797C844CE1](/claim/clm_F6797C844CE1.md)
- 2019-02-02 to 2019-05-04 | money | quarterly_operating_income | 455,826,000 United States dollar | superseded | [clm_C280F9B2BEB5](/claim/clm_C280F9B2BEB5.md)
- 2019-02-02 to 2019-05-04 | money | quarterly_research_and_development | 287,382,000 United States dollar | superseded | [clm_F4F342F4D703](/claim/clm_F4F342F4D703.md)
- 2019-02-02 to 2019-05-04 | money | quarterly_revenue | 1,541,101,000 United States dollar | superseded | [clm_C941029DE55A](/claim/clm_C941029DE55A.md)
- 2019-02-02 to 2019-05-04 | money | shares_outstanding | 368,314,314 shares | superseded | [clm_05D354D31D1F](/claim/clm_05D354D31D1F.md)
- 2019-02-02 to 2019-05-04 | money | total_assets | 21,828,278,000 United States dollar | superseded | [clm_6C2C46947699](/claim/clm_6C2C46947699.md)
- 2019-02-02 to 2019-05-04 | money | total_equity | 11,585,437,000 United States dollar | superseded | [clm_581277A718D6](/claim/clm_581277A718D6.md)
- 2019-05-04 to 2019-08-03 | money | cash_and_equivalents | 713,601,000 United States dollar | superseded | [clm_5337D7688DE3](/claim/clm_5337D7688DE3.md)
- 2019-05-04 to 2019-08-03 | money | quarterly_net_income | 367,937,000 United States dollar | superseded | [clm_D8D4EC7A714D](/claim/clm_D8D4EC7A714D.md)
- 2019-05-04 to 2019-08-03 | money | quarterly_operating_income | 469,695,000 United States dollar | superseded | [clm_E612F3DB47E9](/claim/clm_E612F3DB47E9.md)
- 2019-05-04 to 2019-08-03 | money | quarterly_research_and_development | 285,846,000 United States dollar | superseded | [clm_EC6EEA25DA95](/claim/clm_EC6EEA25DA95.md)
- 2019-05-04 to 2019-08-03 | money | quarterly_revenue | 1,526,602,000 United States dollar | superseded | [clm_AED9A9B28F59](/claim/clm_AED9A9B28F59.md)
- 2019-05-04 to 2019-08-03 | money | shares_outstanding | 369,761,227 shares | superseded | [clm_D8120A0A1CCE](/claim/clm_D8120A0A1CCE.md)
- 2019-05-04 to 2019-08-03 | money | total_assets | 21,776,325,000 United States dollar | superseded | [clm_0A278AA20289](/claim/clm_0A278AA20289.md)
- 2019-05-04 to 2019-08-03 | money | total_equity | 11,742,258,000 United States dollar | superseded | [clm_822128DC6C5D](/claim/clm_822128DC6C5D.md)
- 2019-08-03 to 2019-11-02 | money | cash_and_equivalents | 612,164,000 United States dollar | superseded | [clm_06713E2B45CF](/claim/clm_06713E2B45CF.md)
- 2019-08-03 to 2020-02-01 | money | quarterly_net_income | 362,374,000 United States dollar | superseded | [clm_D9865938B376](/claim/clm_D9865938B376.md)
- 2019-08-03 to 2020-02-01 | money | quarterly_operating_income | 446,726,000 United States dollar | superseded | [clm_5F0CC0ECC2D1](/claim/clm_5F0CC0ECC2D1.md)
- 2019-08-03 to 2020-02-01 | money | quarterly_research_and_development | 280,102,000 United States dollar | superseded | [clm_9E4064F1EBF0](/claim/clm_9E4064F1EBF0.md)
- 2019-08-03 to 2020-02-01 | money | quarterly_revenue | 1,480,143,000 United States dollar | superseded | [clm_04ECAB534143](/claim/clm_04ECAB534143.md)
- 2019-08-03 to 2019-11-02 | money | shares_outstanding | 369,406,136 shares | superseded | [clm_B28D960A03B0](/claim/clm_B28D960A03B0.md)
- 2019-08-03 to 2019-11-02 | money | total_assets | 21,566,650,000 United States dollar | superseded | [clm_77A20D74F85E](/claim/clm_77A20D74F85E.md)
- 2019-08-03 to 2019-11-02 | money | total_equity | 11,790,237,000 United States dollar | superseded | [clm_B4FFEE66CC19](/claim/clm_B4FFEE66CC19.md)
- 2019-11-02 to 2020-02-01 | money | cash_and_equivalents | 648,322,000 United States dollar | superseded | [clm_3D537AC6B3CA](/claim/clm_3D537AC6B3CA.md)
- 2019-11-02 to 2020-10-31 | money | net_income | 1,363,011,000 United States dollar | superseded | [clm_71D0402A9F89](/claim/clm_71D0402A9F89.md)
- 2019-11-02 to 2020-10-31 | money | operating_income | 1,710,608,000 United States dollar | superseded | [clm_A55A061E0AB9](/claim/clm_A55A061E0AB9.md)
- 2019-11-02 to 2020-10-31 | money | research_and_development | 1,130,348,000 United States dollar | superseded | [clm_EBECCC99E843](/claim/clm_EBECCC99E843.md)
- 2019-11-02 to 2020-10-31 | money | revenue | 5,991,065,000 United States dollar | superseded | [clm_686314A3F12C](/claim/clm_686314A3F12C.md)
- 2019-11-02 to 2020-02-01 | money | shares_outstanding | 368,302,369 shares | superseded | [clm_68AC3B6BF1EE](/claim/clm_68AC3B6BF1EE.md)
- 2019-11-02 to 2020-02-01 | money | total_assets | 21,392,641,000 United States dollar | superseded | [clm_CEA8DEE0F7C5](/claim/clm_CEA8DEE0F7C5.md)
- 2019-11-02 to 2020-02-01 | money | total_equity | 11,709,188,000 United States dollar | superseded | [clm_11B046662350](/claim/clm_11B046662350.md)

## 2020

- 2020-02-01 to 2020-05-02 | money | cash_and_equivalents | 654,408,000 United States dollar | superseded | [clm_66713187AB67](/claim/clm_66713187AB67.md)
- 2020-02-01 to 2020-05-02 | money | quarterly_net_income | 203,874,000 United States dollar | superseded | [clm_5939A6300502](/claim/clm_5939A6300502.md)
- 2020-02-01 to 2020-05-02 | money | quarterly_operating_income | 273,428,000 United States dollar | superseded | [clm_CBCD3330EF39](/claim/clm_CBCD3330EF39.md)
- 2020-02-01 to 2020-05-02 | money | quarterly_research_and_development | 257,073,000 United States dollar | superseded | [clm_E5DBB72BA562](/claim/clm_E5DBB72BA562.md)
- 2020-02-01 to 2020-05-02 | money | quarterly_revenue | 1,303,565,000 United States dollar | superseded | [clm_8B7FD477A5A4](/claim/clm_8B7FD477A5A4.md)
- 2020-02-01 to 2020-05-02 | money | shares_outstanding | 368,220,091 shares | superseded | [clm_33422338DF79](/claim/clm_33422338DF79.md)
- 2020-02-01 to 2020-05-02 | money | total_assets | 21,376,827,000 United States dollar | superseded | [clm_14339A01C2FC](/claim/clm_14339A01C2FC.md)
- 2020-02-01 to 2020-05-02 | money | total_equity | 11,689,517,000 United States dollar | superseded | [clm_2C0677DBA59F](/claim/clm_2C0677DBA59F.md)
- 2020-05-02 to 2020-08-01 | money | cash_and_equivalents | 784,937,000 United States dollar | superseded | [clm_33C7325CD4F7](/claim/clm_33C7325CD4F7.md)
- 2020-05-02 to 2020-08-01 | money | quarterly_net_income | 267,696,000 United States dollar | superseded | [clm_A7A9AE4B487A](/claim/clm_A7A9AE4B487A.md)
- 2020-05-02 to 2020-08-01 | money | quarterly_operating_income | 344,020,000 United States dollar | superseded | [clm_B814265F52EF](/claim/clm_B814265F52EF.md)
- 2020-05-02 to 2020-08-01 | money | quarterly_research_and_development | 252,413,000 United States dollar | superseded | [clm_3D63E748A3F8](/claim/clm_3D63E748A3F8.md)
- 2020-05-02 to 2020-08-01 | money | quarterly_revenue | 1,317,060,000 United States dollar | superseded | [clm_7C7944808909](/claim/clm_7C7944808909.md)
- 2020-05-02 to 2020-08-01 | money | shares_outstanding | 368,424,615 shares | superseded | [clm_9F9008B94D3D](/claim/clm_9F9008B94D3D.md)
- 2020-05-02 to 2020-08-01 | money | total_assets | 21,350,938,000 United States dollar | superseded | [clm_4238813D841C](/claim/clm_4238813D841C.md)
- 2020-05-02 to 2020-08-01 | money | total_equity | 11,590,858,000 United States dollar | superseded | [clm_1D79481C864D](/claim/clm_1D79481C864D.md)
- 2020-08-01 to 2020-10-31 | money | cash_and_equivalents | 1,090,264,000 United States dollar | superseded | [clm_39B6C211C23F](/claim/clm_39B6C211C23F.md)
- 2020-08-01 to 2021-01-30 | money | quarterly_net_income | 362,665,000 United States dollar | superseded | [clm_EFB1000D69DD](/claim/clm_EFB1000D69DD.md)
- 2020-08-01 to 2021-01-30 | money | quarterly_operating_income | 419,124,000 United States dollar | superseded | [clm_0CD243BC1ED3](/claim/clm_0CD243BC1ED3.md)
- 2020-08-01 to 2021-01-30 | money | quarterly_research_and_development | 260,794,000 United States dollar | superseded | [clm_022426CD21E3](/claim/clm_022426CD21E3.md)
- 2020-08-01 to 2021-01-30 | money | quarterly_revenue | 1,456,136,000 United States dollar | superseded | [clm_3ABD60C6544C](/claim/clm_3ABD60C6544C.md)
- 2020-08-01 to 2020-10-31 | money | shares_outstanding | 369,166,257 shares | superseded | [clm_2793CF7415A2](/claim/clm_2793CF7415A2.md)
- 2020-08-01 to 2020-10-31 | money | total_assets | 21,599,568,000 United States dollar | superseded | [clm_938FF3355B6D](/claim/clm_938FF3355B6D.md)
- 2020-08-01 to 2020-10-31 | money | total_equity | 11,777,560,000 United States dollar | superseded | [clm_98205A02E9C4](/claim/clm_98205A02E9C4.md)
- 2020-10-31 to 2021-01-30 | money | cash_and_equivalents | 1,055,860,000 United States dollar | superseded | [clm_EB09FCDF9F93](/claim/clm_EB09FCDF9F93.md)
- 2020-10-31 to 2021-10-30 | money | net_income | 1,220,761,000 United States dollar | superseded | [clm_92813CB0B7E4](/claim/clm_92813CB0B7E4.md)
- 2020-10-31 to 2021-10-30 | money | operating_income | 1,498,244,000 United States dollar | superseded | [clm_99643037E6DF](/claim/clm_99643037E6DF.md)
- 2020-10-31 to 2021-10-30 | money | research_and_development | 1,050,519,000 United States dollar | superseded | [clm_2DDFDACC8ED3](/claim/clm_2DDFDACC8ED3.md)
- 2020-10-31 to 2021-10-30 | money | revenue | 5,603,056,000 United States dollar | superseded | [clm_BE146C756A73](/claim/clm_BE146C756A73.md)
- 2020-10-31 to 2021-01-30 | money | shares_outstanding | 369,484,899 shares | superseded | [clm_6777A303804D](/claim/clm_6777A303804D.md)
- 2020-10-31 to 2021-01-30 | money | total_assets | 21,468,603,000 United States dollar | superseded | [clm_97274B184D27](/claim/clm_97274B184D27.md)
- 2020-10-31 to 2021-01-30 | money | total_equity | 11,997,945,000 United States dollar | superseded | [clm_09187C7D0D75](/claim/clm_09187C7D0D75.md)

## 2021

- 2021-01-30 to 2021-05-01 | money | cash_and_equivalents | 1,048,063,000 United States dollar | superseded | [clm_643E74B2EA5E](/claim/clm_643E74B2EA5E.md)
- 2021-01-30 to 2021-05-01 | money | quarterly_net_income | 388,519,000 United States dollar | superseded | [clm_74D614DE19A6](/claim/clm_74D614DE19A6.md)
- 2021-01-30 to 2021-05-01 | money | quarterly_operating_income | 463,860,000 United States dollar | superseded | [clm_503453CD189C](/claim/clm_503453CD189C.md)
- 2021-01-30 to 2021-05-01 | money | quarterly_research_and_development | 288,150,000 United States dollar | superseded | [clm_9FFAA5BC5F42](/claim/clm_9FFAA5BC5F42.md)
- 2021-01-30 to 2021-05-01 | money | quarterly_revenue | 1,558,458,000 United States dollar | superseded | [clm_07D4B0C416B6](/claim/clm_07D4B0C416B6.md)
- 2021-01-30 to 2021-05-01 | money | shares_outstanding | 368,893,742 shares | superseded | [clm_3EBB8D53BF93](/claim/clm_3EBB8D53BF93.md)
- 2021-01-30 to 2021-05-01 | money | total_assets | 21,440,110,000 United States dollar | superseded | [clm_EB6C8AE2E0D9](/claim/clm_EB6C8AE2E0D9.md)
- 2021-01-30 to 2021-05-01 | money | total_equity | 12,087,746,000 United States dollar | superseded | [clm_79EED28443B9](/claim/clm_79EED28443B9.md)
- 2021-05-01 to 2021-07-31 | money | cash_and_equivalents | 1,305,216,000 United States dollar | superseded | [clm_29025A08794B](/claim/clm_29025A08794B.md)
- 2021-05-01 to 2021-07-31 | money | quarterly_net_income | 422,905,000 United States dollar | superseded | [clm_9D7A7FED9DCF](/claim/clm_9D7A7FED9DCF.md)
- 2021-05-01 to 2021-07-31 | money | quarterly_operating_income | 519,690,000 United States dollar | superseded | [clm_C6BC8FFF9B90](/claim/clm_C6BC8FFF9B90.md)
- 2021-05-01 to 2021-07-31 | money | quarterly_research_and_development | 302,238,000 United States dollar | superseded | [clm_BB04E4523F85](/claim/clm_BB04E4523F85.md)
- 2021-05-01 to 2021-07-31 | money | quarterly_revenue | 1,661,407,000 United States dollar | superseded | [clm_75015A49239B](/claim/clm_75015A49239B.md)
- 2021-05-01 to 2021-07-31 | money | shares_outstanding | 368,826,918 shares | superseded | [clm_FD6CBEBEEABE](/claim/clm_FD6CBEBEEABE.md)
- 2021-05-01 to 2021-07-31 | money | total_assets | 21,588,217,000 United States dollar | superseded | [clm_74846D3F9833](/claim/clm_74846D3F9833.md)
- 2021-05-01 to 2021-07-31 | money | total_equity | 12,167,104,000 United States dollar | superseded | [clm_9D584F422A21](/claim/clm_9D584F422A21.md)
- 2021-07-31 to 2021-10-30 | money | cash_and_equivalents | 1,480,701,000 United States dollar | superseded | [clm_8770D11E6E42](/claim/clm_8770D11E6E42.md)
- 2021-07-31 to 2022-01-29 | money | quarterly_net_income | 503,311,000 United States dollar | superseded | [clm_6E4695F72D26](/claim/clm_6E4695F72D26.md)
- 2021-07-31 to 2022-01-29 | money | quarterly_operating_income | 609,646,000 United States dollar | superseded | [clm_295595D1E20A](/claim/clm_295595D1E20A.md)
- 2021-07-31 to 2022-01-29 | money | quarterly_research_and_development | 306,617,000 United States dollar | superseded | [clm_595B411D9D68](/claim/clm_595B411D9D68.md)
- 2021-07-31 to 2022-01-29 | money | quarterly_revenue | 1,758,853,000 United States dollar | superseded | [clm_B9BCF3F25D63](/claim/clm_B9BCF3F25D63.md)
- 2021-07-31 to 2021-10-30 | money | shares_outstanding | 368,214,341 shares | superseded | [clm_6286635D73B5](/claim/clm_6286635D73B5.md)
- 2021-07-31 to 2021-10-30 | money | total_assets | 21,641,190,000 United States dollar | superseded | [clm_BBFEFA7BD214](/claim/clm_BBFEFA7BD214.md)
- 2021-07-31 to 2021-10-30 | money | total_equity | 12,263,963,000 United States dollar | superseded | [clm_1A9E7D0D834A](/claim/clm_1A9E7D0D834A.md)
- 2021-10-30 to 2022-01-29 | money | cash_and_equivalents | 1,977,964,000 United States dollar | superseded | [clm_CA8278173E8B](/claim/clm_CA8278173E8B.md)
- 2021-10-30 to 2022-10-29 | money | net_income | 1,390,422,000 United States dollar | superseded | [clm_D1DC1806A12A](/claim/clm_D1DC1806A12A.md)
- 2021-10-30 to 2022-10-29 | money | operating_income | 1,692,201,000 United States dollar | superseded | [clm_2F28DA168332](/claim/clm_2F28DA168332.md)
- 2021-10-30 to 2022-10-29 | money | research_and_development | 1,296,126,000 United States dollar | superseded | [clm_2DC912EB55EC](/claim/clm_2DC912EB55EC.md)
- 2021-10-30 to 2022-10-29 | money | revenue | 7,318,286,000 United States dollar | superseded | [clm_513BCC7158AB](/claim/clm_513BCC7158AB.md)
- 2021-10-30 to 2022-01-29 | money | shares_outstanding | 525,330,672 shares | superseded | [clm_5DBEFF125A49](/claim/clm_5DBEFF125A49.md)
- 2021-10-30 to 2022-01-29 | money | total_assets | 52,322,071,000 United States dollar | superseded | [clm_43A379E3AA06](/claim/clm_43A379E3AA06.md)
- 2021-10-30 to 2022-01-29 | money | total_equity | 37,992,542,000 United States dollar | superseded | [clm_74B56AF6D9B7](/claim/clm_74B56AF6D9B7.md)

## 2022

- 2022-01-29 to 2022-04-30 | money | cash_and_equivalents | 1,790,399,000 United States dollar | superseded | [clm_741786B9E9E2](/claim/clm_741786B9E9E2.md)
- 2022-01-29 to 2022-04-30 | money | quarterly_net_income | 280,077,000 United States dollar | superseded | [clm_5EF7D3053EB1](/claim/clm_5EF7D3053EB1.md)
- 2022-01-29 to 2022-04-30 | money | quarterly_operating_income | 364,757,000 United States dollar | superseded | [clm_5589B0F1D72C](/claim/clm_5589B0F1D72C.md)
- 2022-01-29 to 2022-04-30 | money | quarterly_research_and_development | 426,780,000 United States dollar | superseded | [clm_10C98F63061D](/claim/clm_10C98F63061D.md)
- 2022-01-29 to 2022-04-30 | money | quarterly_revenue | 2,684,293,000 United States dollar | superseded | [clm_F6448250242C](/claim/clm_F6448250242C.md)
- 2022-01-29 to 2022-04-30 | money | shares_outstanding | 523,315,130 shares | superseded | [clm_530E22B27CA4](/claim/clm_530E22B27CA4.md)
- 2022-01-29 to 2022-04-30 | money | total_assets | 51,215,614,000 United States dollar | superseded | [clm_C9299D043DD6](/claim/clm_C9299D043DD6.md)
- 2022-01-29 to 2022-04-30 | money | total_equity | 37,427,312,000 United States dollar | superseded | [clm_4C331C16F8D0](/claim/clm_4C331C16F8D0.md)
- 2022-04-30 to 2022-07-30 | money | cash_and_equivalents | 1,737,733,000 United States dollar | superseded | [clm_5405AB2CCC91](/claim/clm_5405AB2CCC91.md)
- 2022-04-30 to 2022-07-30 | money | quarterly_net_income | 783,273,000 United States dollar | superseded | [clm_B96CDA57E59A](/claim/clm_B96CDA57E59A.md)
- 2022-04-30 to 2022-07-30 | money | quarterly_operating_income | 918,161,000 United States dollar | superseded | [clm_02F184DB1AAB](/claim/clm_02F184DB1AAB.md)
- 2022-04-30 to 2022-07-30 | money | quarterly_research_and_development | 420,901,000 United States dollar | superseded | [clm_22F6A6689B8E](/claim/clm_22F6A6689B8E.md)
- 2022-04-30 to 2022-07-30 | money | quarterly_revenue | 2,972,064,000 United States dollar | superseded | [clm_854BDC85946F](/claim/clm_854BDC85946F.md)
- 2022-04-30 to 2022-07-30 | money | shares_outstanding | 519,806,028 shares | superseded | [clm_0F7D7E9CC427](/claim/clm_0F7D7E9CC427.md)
- 2022-04-30 to 2022-07-30 | money | total_assets | 50,800,652,000 United States dollar | superseded | [clm_78B608DDBAB6](/claim/clm_78B608DDBAB6.md)
- 2022-04-30 to 2022-07-30 | money | total_equity | 37,099,782,000 United States dollar | superseded | [clm_F4FF4DF257BB](/claim/clm_F4FF4DF257BB.md)
- 2022-07-30 to 2022-10-29 | money | cash_and_equivalents | 1,524,960,000 United States dollar | superseded | [clm_90B72EDE414F](/claim/clm_90B72EDE414F.md)
- 2022-07-30 to 2023-01-28 | money | quarterly_net_income | 748,985,000 United States dollar | superseded | [clm_146580A1A189](/claim/clm_146580A1A189.md)
- 2022-07-30 to 2023-01-28 | money | quarterly_operating_income | 893,306,000 United States dollar | superseded | [clm_4CA51AD0B541](/claim/clm_4CA51AD0B541.md)
- 2022-07-30 to 2023-01-28 | money | quarterly_research_and_development | 431,829,000 United States dollar | superseded | [clm_FE8FA888BEE1](/claim/clm_FE8FA888BEE1.md)
- 2022-07-30 to 2023-01-28 | money | quarterly_revenue | 3,109,880,000 United States dollar | superseded | [clm_180C2A4686F5](/claim/clm_180C2A4686F5.md)
- 2022-07-30 to 2022-10-29 | money | shares_outstanding | 514,341,531 shares | superseded | [clm_B7FB347D9C2B](/claim/clm_B7FB347D9C2B.md)
- 2022-07-30 to 2022-10-29 | money | total_assets | 50,346,170,000 United States dollar | superseded | [clm_63FED153AB59](/claim/clm_63FED153AB59.md)
- 2022-07-30 to 2022-10-29 | money | total_equity | 36,638,591,000 United States dollar | superseded | [clm_1A0DC44E528F](/claim/clm_1A0DC44E528F.md)
- 2022-10-29 to 2023-01-28 | money | cash_and_equivalents | 1,470,572,000 United States dollar | superseded | [clm_ABA52EA30125](/claim/clm_ABA52EA30125.md)
- 2022-10-29 to 2023-10-28 | money | net_income | 2,748,561,000 United States dollar | superseded | [clm_D4B3E2FD7BD5](/claim/clm_D4B3E2FD7BD5.md)
- 2022-10-29 to 2023-10-28 | money | operating_income | 3,278,700,000 United States dollar | superseded | [clm_3E5D30FEEA73](/claim/clm_3E5D30FEEA73.md)
- 2022-10-29 to 2023-10-28 | money | research_and_development | 1,700,518,000 United States dollar | superseded | [clm_DF4776B31774](/claim/clm_DF4776B31774.md)
- 2022-10-29 to 2023-10-28 | money | revenue | 12,013,953,000 United States dollar | superseded | [clm_D408D55FD13B](/claim/clm_D408D55FD13B.md)
- 2022-10-29 to 2023-01-28 | money | shares_outstanding | 509,295,941 shares | superseded | [clm_77F609558D7B](/claim/clm_77F609558D7B.md)
- 2022-10-29 to 2023-01-28 | money | total_assets | 50,302,350,000 United States dollar | superseded | [clm_DE5C73C5F51F](/claim/clm_DE5C73C5F51F.md)
- 2022-10-29 to 2023-01-28 | money | total_equity | 36,465,323,000 United States dollar | superseded | [clm_5E6AE7D0324D](/claim/clm_5E6AE7D0324D.md)

## 2023

- 2023-01-28 to 2023-04-29 | money | cash_and_equivalents | 1,670,462,000 United States dollar | superseded | [clm_57F7BCB9BE9F](/claim/clm_57F7BCB9BE9F.md)
- 2023-01-28 to 2023-04-29 | money | quarterly_net_income | 961,474,000 United States dollar | superseded | [clm_F7C06849E176](/claim/clm_F7C06849E176.md)
- 2023-01-28 to 2023-04-29 | money | quarterly_operating_income | 1,130,820,000 United States dollar | superseded | [clm_13B448714BAA](/claim/clm_13B448714BAA.md)
- 2023-01-28 to 2023-04-29 | money | quarterly_research_and_development | 414,095,000 United States dollar | superseded | [clm_7868D2637773](/claim/clm_7868D2637773.md)
- 2023-01-28 to 2023-04-29 | money | quarterly_revenue | 3,249,630,000 United States dollar | superseded | [clm_20126ACCE564](/claim/clm_20126ACCE564.md)
- 2023-01-28 to 2023-04-29 | money | shares_outstanding | 505,852,499 shares | superseded | [clm_AD8F41A37B4E](/claim/clm_AD8F41A37B4E.md)
- 2023-01-28 to 2023-04-29 | money | total_assets | 50,234,520,000 United States dollar | superseded | [clm_429BABF4496D](/claim/clm_429BABF4496D.md)
- 2023-01-28 to 2023-04-29 | money | total_equity | 36,531,485,000 United States dollar | superseded | [clm_CA913B26112C](/claim/clm_CA913B26112C.md)
- 2023-04-29 to 2023-07-29 | money | cash_and_equivalents | 1,177,609,000 United States dollar | superseded | [clm_FFA9D89FB5D2](/claim/clm_FFA9D89FB5D2.md)
- 2023-04-29 to 2023-07-29 | money | quarterly_net_income | 977,656,000 United States dollar | superseded | [clm_81C8AB81AC8A](/claim/clm_81C8AB81AC8A.md)
- 2023-04-29 to 2023-07-29 | money | quarterly_operating_income | 1,128,384,000 United States dollar | superseded | [clm_6830D9EB664E](/claim/clm_6830D9EB664E.md)
- 2023-04-29 to 2023-07-29 | money | quarterly_research_and_development | 415,754,000 United States dollar | superseded | [clm_B7D344560B9E](/claim/clm_B7D344560B9E.md)
- 2023-04-29 to 2023-07-29 | money | quarterly_revenue | 3,262,930,000 United States dollar | superseded | [clm_F4F7120E2F4C](/claim/clm_F4F7120E2F4C.md)
- 2023-04-29 to 2023-07-29 | money | shares_outstanding | 501,418,304 shares | superseded | [clm_822E59BFCDB1](/claim/clm_822E59BFCDB1.md)
- 2023-04-29 to 2023-07-29 | money | total_assets | 49,544,739,000 United States dollar | superseded | [clm_891F4A595BBF](/claim/clm_891F4A595BBF.md)
- 2023-04-29 to 2023-07-29 | money | total_equity | 36,013,224,000 United States dollar | superseded | [clm_D4C73952DD76](/claim/clm_D4C73952DD76.md)
- 2023-07-29 to 2023-10-28 | money | cash_and_equivalents | 1,149,246,000 United States dollar | superseded | [clm_FA8A6616825A](/claim/clm_FA8A6616825A.md)
- 2023-07-29 to 2024-02-03 | money | quarterly_net_income | 877,019,000 United States dollar | superseded | [clm_A00A8084B30E](/claim/clm_A00A8084B30E.md)
- 2023-07-29 to 2024-02-03 | money | quarterly_operating_income | 929,493,000 United States dollar | superseded | [clm_E362EC3037BE](/claim/clm_E362EC3037BE.md)
- 2023-07-29 to 2024-02-03 | money | quarterly_research_and_development | 423,751,000 United States dollar | superseded | [clm_CD2A646C5239](/claim/clm_CD2A646C5239.md)
- 2023-07-29 to 2024-02-03 | money | quarterly_revenue | 3,076,495,000 United States dollar | superseded | [clm_0185112E13E6](/claim/clm_0185112E13E6.md)
- 2023-07-29 to 2023-10-28 | money | shares_outstanding | 498,313,956 shares | superseded | [clm_8DF6F01E5AD7](/claim/clm_8DF6F01E5AD7.md)
- 2023-07-29 to 2023-10-28 | money | total_assets | 49,346,739,000 United States dollar | superseded | [clm_B2758ACD9D79](/claim/clm_B2758ACD9D79.md)
- 2023-07-29 to 2023-10-28 | money | total_equity | 35,903,746,000 United States dollar | superseded | [clm_57792C2464A0](/claim/clm_57792C2464A0.md)
- 2023-10-28 to 2024-02-03 | money | cash_and_equivalents | 958,061,000 United States dollar | superseded | [clm_6537C472ACCD](/claim/clm_6537C472ACCD.md)
- 2023-10-28 to 2024-11-02 | money | net_income | 3,314,579,000 United States dollar | superseded | [clm_59959DFE506B](/claim/clm_59959DFE506B.md)
- 2023-10-28 to 2024-11-02 | money | operating_income | 3,823,112,000 United States dollar | superseded | [clm_8CF00E8A1602](/claim/clm_8CF00E8A1602.md)
- 2023-10-28 to 2024-11-02 | money | research_and_development | 1,660,194,000 United States dollar | superseded | [clm_7C714A70B7A5](/claim/clm_7C714A70B7A5.md)
- 2023-10-28 to 2024-11-02 | money | revenue | 12,305,539,000 United States dollar | superseded | [clm_F3E1AAA07837](/claim/clm_F3E1AAA07837.md)
- 2023-10-28 to 2024-02-03 | money | shares_outstanding | 496,261,678 shares | superseded | [clm_E639A58AADE7](/claim/clm_E639A58AADE7.md)
- 2023-10-28 to 2024-02-03 | money | total_assets | 48,794,478,000 United States dollar | superseded | [clm_43E5C7F424E9](/claim/clm_43E5C7F424E9.md)
- 2023-10-28 to 2024-02-03 | money | total_equity | 35,565,122,000 United States dollar | superseded | [clm_F086A507246C](/claim/clm_F086A507246C.md)

## 2024

- 2024-02-03 to 2024-05-04 | money | cash_and_equivalents | 1,303,560,000 United States dollar | superseded | [clm_ED816608C1FB](/claim/clm_ED816608C1FB.md)
- 2024-02-03 to 2024-05-04 | money | quarterly_net_income | 462,727,000 United States dollar | superseded | [clm_480FE3BB9AD7](/claim/clm_480FE3BB9AD7.md)
- 2024-02-03 to 2024-05-04 | money | quarterly_operating_income | 585,964,000 United States dollar | superseded | [clm_A4C97A795209](/claim/clm_A4C97A795209.md)
- 2024-02-03 to 2024-05-04 | money | quarterly_research_and_development | 391,427,000 United States dollar | superseded | [clm_0FF563AA436E](/claim/clm_0FF563AA436E.md)
- 2024-02-03 to 2024-05-04 | money | quarterly_revenue | 2,512,704,000 United States dollar | superseded | [clm_6453B32908DC](/claim/clm_6453B32908DC.md)
- 2024-02-03 to 2024-05-04 | money | shares_outstanding | 495,908,150 shares | superseded | [clm_3C28ED38A0FE](/claim/clm_3C28ED38A0FE.md)
- 2024-02-03 to 2024-05-04 | money | total_assets | 48,388,464,000 United States dollar | superseded | [clm_88EB4755A987](/claim/clm_88EB4755A987.md)
- 2024-02-03 to 2024-05-04 | money | total_equity | 35,548,073,000 United States dollar | superseded | [clm_C4075B9481F1](/claim/clm_C4075B9481F1.md)
- 2024-05-04 to 2024-08-03 | money | cash_and_equivalents | 1,939,695,000 United States dollar | superseded | [clm_64C470C36100](/claim/clm_64C470C36100.md)
- 2024-05-04 to 2024-08-03 | money | quarterly_net_income | 302,242,000 United States dollar | superseded | [clm_E1E3F1233F24](/claim/clm_E1E3F1233F24.md)
- 2024-05-04 to 2024-08-03 | money | quarterly_operating_income | 386,123,000 United States dollar | superseded | [clm_CFC3A52E3DC1](/claim/clm_CFC3A52E3DC1.md)
- 2024-05-04 to 2024-08-03 | money | quarterly_research_and_development | 354,862,000 United States dollar | superseded | [clm_554DAC1EC1C1](/claim/clm_554DAC1EC1C1.md)
- 2024-05-04 to 2024-08-03 | money | quarterly_revenue | 2,159,039,000 United States dollar | superseded | [clm_1D075C255A31](/claim/clm_1D075C255A31.md)
- 2024-05-04 to 2024-08-03 | money | shares_outstanding | 496,216,857 shares | superseded | [clm_8C61DB1C6C87](/claim/clm_8C61DB1C6C87.md)
- 2024-05-04 to 2024-08-03 | money | total_assets | 48,861,866,000 United States dollar | superseded | [clm_6EC5432AA0AE](/claim/clm_6EC5432AA0AE.md)
- 2024-05-04 to 2024-08-03 | money | total_equity | 35,248,789,000 United States dollar | superseded | [clm_51463CD448DC](/claim/clm_51463CD448DC.md)
- 2024-08-03 to 2024-11-02 | money | cash_and_equivalents | 2,106,032,000 United States dollar | superseded | [clm_F88B95C8246B](/claim/clm_F88B95C8246B.md)
- 2024-08-03 to 2025-02-01 | money | quarterly_net_income | 392,232,000 United States dollar | superseded | [clm_05811A0CDB28](/claim/clm_05811A0CDB28.md)
- 2024-08-03 to 2025-02-01 | money | quarterly_operating_income | 491,319,000 United States dollar | superseded | [clm_DAF897C3A9B7](/claim/clm_DAF897C3A9B7.md)
- 2024-08-03 to 2025-02-01 | money | quarterly_research_and_development | 362,671,000 United States dollar | superseded | [clm_4756C823D26D](/claim/clm_4756C823D26D.md)
- 2024-08-03 to 2025-02-01 | money | quarterly_revenue | 2,312,209,000 United States dollar | superseded | [clm_03D86B9A54EE](/claim/clm_03D86B9A54EE.md)
- 2024-08-03 to 2024-11-02 | money | shares_outstanding | 496,493,455 shares | superseded | [clm_99C215EC718B](/claim/clm_99C215EC718B.md)
- 2024-08-03 to 2024-11-02 | money | total_assets | 48,618,374,000 United States dollar | superseded | [clm_02F5B311EFF6](/claim/clm_02F5B311EFF6.md)
- 2024-08-03 to 2024-11-02 | money | total_equity | 35,190,109,000 United States dollar | superseded | [clm_DBBC6A1FCCB2](/claim/clm_DBBC6A1FCCB2.md)
- 2024-11-02 to 2025-02-01 | money | cash_and_equivalents | 1,991,342,000 United States dollar | superseded | [clm_44B07E22D3C7](/claim/clm_44B07E22D3C7.md)
- 2024-11-02 to 2025-11-01 | money | net_income | 1,635,273,000 United States dollar | superseded | [clm_8A191A32982E](/claim/clm_8A191A32982E.md)
- 2024-11-02 to 2025-11-01 | money | operating_income | 2,032,798,000 United States dollar | superseded | [clm_DE020FADA8AF](/claim/clm_DE020FADA8AF.md)
- 2024-11-02 to 2025-11-01 | money | research_and_development | 1,487,863,000 United States dollar | superseded | [clm_E3F2CA38D1F2](/claim/clm_E3F2CA38D1F2.md)
- 2024-11-02 to 2025-11-01 | money | revenue | 9,427,157,000 United States dollar | superseded | [clm_ADA2C1ECB869](/claim/clm_ADA2C1ECB869.md)
- 2024-11-02 to 2025-02-01 | money | shares_outstanding | 496,296,854 shares | superseded | [clm_D2AD181EBAD2](/claim/clm_D2AD181EBAD2.md)
- 2024-11-02 to 2025-02-01 | money | total_assets | 48,228,277,000 United States dollar | superseded | [clm_CB6FF58A8AA4](/claim/clm_CB6FF58A8AA4.md)
- 2024-11-02 to 2025-02-01 | money | total_equity | 35,176,317,000 United States dollar | superseded | [clm_C183B6DD4BA4](/claim/clm_C183B6DD4BA4.md)

## 2025

- 2025-02-01 to 2025-05-03 | money | cash_and_equivalents | 2,349,994,000 United States dollar | superseded | [clm_77CD15A165AC](/claim/clm_77CD15A165AC.md)
- 2025-02-01 to 2025-05-03 | money | quarterly_net_income | 391,316,000 United States dollar | superseded | [clm_4EC7419FF059](/claim/clm_4EC7419FF059.md)
- 2025-02-01 to 2025-05-03 | money | quarterly_operating_income | 491,313,000 United States dollar | superseded | [clm_438B37B98436](/claim/clm_438B37B98436.md)
- 2025-02-01 to 2025-05-03 | money | quarterly_research_and_development | 402,892,000 United States dollar | superseded | [clm_567D6479E113](/claim/clm_567D6479E113.md)
- 2025-02-01 to 2025-05-03 | money | quarterly_revenue | 2,423,174,000 United States dollar | superseded | [clm_812CBA7E45AA](/claim/clm_812CBA7E45AA.md)
- 2025-02-01 to 2025-05-03 | money | shares_outstanding | 495,976,483 shares | superseded | [clm_110DE3D220BB](/claim/clm_110DE3D220BB.md)
- 2025-02-01 to 2025-05-03 | money | total_assets | 47,967,546,000 United States dollar | superseded | [clm_6B91627C0DE9](/claim/clm_6B91627C0DE9.md)
- 2025-02-01 to 2025-05-03 | money | total_equity | 35,070,535,000 United States dollar | superseded | [clm_001219C1F47A](/claim/clm_001219C1F47A.md)
- 2025-05-03 to 2025-08-02 | money | cash_and_equivalents | 2,376,235,000 United States dollar | superseded | [clm_B8F43C917C32](/claim/clm_B8F43C917C32.md)
- 2025-05-03 to 2025-08-02 | money | quarterly_net_income | 569,770,000 United States dollar | superseded | [clm_F23E5112754C](/claim/clm_F23E5112754C.md)
- 2025-05-03 to 2025-08-02 | money | quarterly_operating_income | 677,944,000 United States dollar | superseded | [clm_04CFDD215FD7](/claim/clm_04CFDD215FD7.md)
- 2025-05-03 to 2025-08-02 | money | quarterly_research_and_development | 441,837,000 United States dollar | superseded | [clm_808A4A451F65](/claim/clm_808A4A451F65.md)
- 2025-05-03 to 2025-08-02 | money | quarterly_revenue | 2,640,068,000 United States dollar | superseded | [clm_4BB53C7A2873](/claim/clm_4BB53C7A2873.md)
- 2025-05-03 to 2025-08-02 | money | shares_outstanding | 496,248,196 shares | superseded | [clm_FDA11062066B](/claim/clm_FDA11062066B.md)
- 2025-05-03 to 2025-08-02 | money | total_assets | 47,344,487,000 United States dollar | superseded | [clm_FBB1A0F74FB1](/claim/clm_FBB1A0F74FB1.md)
- 2025-05-03 to 2025-08-02 | money | total_equity | 35,010,620,000 United States dollar | superseded | [clm_58EBD0DD453B](/claim/clm_58EBD0DD453B.md)
- 2025-08-02 to 2025-11-01 | money | cash_and_equivalents | 2,321,191,000 United States dollar | superseded | [clm_58B52D2B3EC3](/claim/clm_58B52D2B3EC3.md)
- 2025-08-02 to 2026-01-31 | money | quarterly_net_income | 518,518,000 United States dollar | superseded | [clm_46E7DA1C49AB](/claim/clm_46E7DA1C49AB.md)
- 2025-08-02 to 2026-01-31 | money | quarterly_operating_income | 818,028,000 United States dollar | superseded | [clm_3055E508D1F0](/claim/clm_3055E508D1F0.md)
- 2025-08-02 to 2026-01-31 | money | quarterly_research_and_development | 454,251,000 United States dollar | superseded | [clm_B13DF8C2BBC4](/claim/clm_B13DF8C2BBC4.md)
- 2025-08-02 to 2026-01-31 | money | quarterly_revenue | 2,880,348,000 United States dollar | superseded | [clm_207810B02D2D](/claim/clm_207810B02D2D.md)
- 2025-08-02 to 2025-11-01 | money | shares_outstanding | 491,955,436 shares | superseded | [clm_74D29E01D346](/claim/clm_74D29E01D346.md)
- 2025-08-02 to 2025-11-01 | money | total_assets | 48,192,601,000 United States dollar | superseded | [clm_8F2817369CD6](/claim/clm_8F2817369CD6.md)
- 2025-08-02 to 2025-11-01 | money | total_equity | 34,085,842,000 United States dollar | superseded | [clm_D3EE94090D0F](/claim/clm_D3EE94090D0F.md)
- 2025-11-01 to 2026-01-31 | money | cash_and_equivalents | 2,499,406,000 United States dollar | superseded | [clm_8200780D1272](/claim/clm_8200780D1272.md)
- 2025-11-01 | money | net_income | 2,267,342,000 United States dollar | valid | [clm_D61346C6A954](/claim/clm_D61346C6A954.md)
- 2025-11-01 | money | operating_income | 2,932,496,000 United States dollar | valid | [clm_43E07B8640F7](/claim/clm_43E07B8640F7.md)
- 2025-11-01 | money | research_and_development | 1,766,001,000 United States dollar | valid | [clm_3B196CC3DC66](/claim/clm_3B196CC3DC66.md)
- 2025-11-01 | money | revenue | 11,019,707,000 United States dollar | valid | [clm_6EC77B00A9AA](/claim/clm_6EC77B00A9AA.md)
- 2025-11-01 to 2026-01-31 | money | shares_outstanding | 489,654,097 shares | superseded | [clm_88550FECD696](/claim/clm_88550FECD696.md)
- 2025-11-01 to 2026-01-31 | money | total_assets | 47,992,712,000 United States dollar | superseded | [clm_89E467505E01](/claim/clm_89E467505E01.md)
- 2025-11-01 to 2026-01-31 | money | total_equity | 33,815,755,000 United States dollar | superseded | [clm_3CC97023B317](/claim/clm_3CC97023B317.md)

## 2026

- 2026-01-31 to 2026-05-02 | money | cash_and_equivalents | 2,905,860,000 United States dollar | superseded | [clm_30C92013EAED](/claim/clm_30C92013EAED.md)
- 2026-01-31 to 2026-05-02 | money | quarterly_net_income | 830,826,000 United States dollar | superseded | [clm_52DCBF0A4573](/claim/clm_52DCBF0A4573.md)
- 2026-01-31 to 2026-05-02 | money | quarterly_operating_income | 997,026,000 United States dollar | superseded | [clm_1C67ECF8ED81](/claim/clm_1C67ECF8ED81.md)
- 2026-01-31 to 2026-05-02 | money | quarterly_research_and_development | 467,400,000 United States dollar | superseded | [clm_DE44BA0BF467](/claim/clm_DE44BA0BF467.md)
- 2026-01-31 to 2026-05-02 | money | quarterly_revenue | 3,160,263,000 United States dollar | superseded | [clm_33D3D16BE2B6](/claim/clm_33D3D16BE2B6.md)
- 2026-01-31 to 2026-05-02 | money | shares_outstanding | 488,204,157 shares | superseded | [clm_F6B1E82E317C](/claim/clm_F6B1E82E317C.md)
- 2026-01-31 to 2026-05-02 | money | total_assets | 47,991,190,000 United States dollar | superseded | [clm_3110734149C5](/claim/clm_3110734149C5.md)
- 2026-01-31 to 2026-05-02 | money | total_equity | 33,787,259,000 United States dollar | superseded | [clm_F67FAE70B87E](/claim/clm_F67FAE70B87E.md)
- 2026-05-02 to 2026-08-01 | money | cash_and_equivalents | 2,436,916,000 United States dollar | superseded | [clm_040A9144DEDD](/claim/clm_040A9144DEDD.md)
- 2026-05-02 to 2026-08-01 | money | quarterly_net_income | 1,176,350,000 United States dollar | superseded | [clm_66FAC4902E5D](/claim/clm_66FAC4902E5D.md)
- 2026-05-02 to 2026-08-01 | money | quarterly_operating_income | 1,379,680,000 United States dollar | superseded | [clm_F1BBFA2A397E](/claim/clm_F1BBFA2A397E.md)
- 2026-05-02 to 2026-08-01 | money | quarterly_research_and_development | 509,323,000 United States dollar | superseded | [clm_A5C1645838DC](/claim/clm_A5C1645838DC.md)
- 2026-05-02 to 2026-08-01 | money | quarterly_revenue | 3,623,465,000 United States dollar | superseded | [clm_E3AFB46506CB](/claim/clm_E3AFB46506CB.md)
- 2026-05-02 to 2026-08-01 | money | shares_outstanding | 487,087,040 shares | superseded | [clm_9BCE5E51608B](/claim/clm_9BCE5E51608B.md)
- 2026-05-02 to 2026-08-01 | money | total_assets | 47,949,095,000 United States dollar | superseded | [clm_3195FE34A3D3](/claim/clm_3195FE34A3D3.md)
- 2026-05-02 to 2026-08-01 | money | total_equity | 33,742,033,000 United States dollar | superseded | [clm_496C99C8714C](/claim/clm_496C99C8714C.md)
- 2026-08-01 | money | cash_and_equivalents | 2,165,870,000 United States dollar | valid | [clm_84292F183D85](/claim/clm_84292F183D85.md)
- 2026-08-01 | money | quarterly_net_income | 1,340,090,000 United States dollar | valid | [clm_5AB913704890](/claim/clm_5AB913704890.md)
- 2026-08-01 | money | quarterly_operating_income | 1,612,969,000 United States dollar | valid | [clm_DADBE5372013](/claim/clm_DADBE5372013.md)
- 2026-08-01 | money | quarterly_research_and_development | 533,480,000 United States dollar | valid | [clm_1F043B79E4F9](/claim/clm_1F043B79E4F9.md)
- 2026-08-01 | money | quarterly_revenue | 4,021,899,000 United States dollar | valid | [clm_C466CED17C04](/claim/clm_C466CED17C04.md)
- 2026-08-01 | money | shares_outstanding | 484,565,465 shares | valid | [clm_F78B8F1B629F](/claim/clm_F78B8F1B629F.md)
- 2026-08-01 | money | total_assets | 48,424,417,000 United States dollar | valid | [clm_0037E60B2116](/claim/clm_0037E60B2116.md)
- 2026-08-01 | money | total_equity | 33,550,897,000 United States dollar | valid | [clm_1096F359CC21](/claim/clm_1096F359CC21.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.